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The purpose of this dissertation is to investigate the heterogeneity in patterns of 
aging and the factors throughout the life course that shape them.  By focusing on 
variability within the population we are able to advance our knowledge of how 
circumstances throughout the life course affect the way individuals age.  We find that the 
paths to disease and longevity are diverse and that the social environment plays an 
important role in shaping these patterns.  Our results support a wide body of literature 
showing that morbidity is not an inevitable consequence of aging, even in the oldest old 
population.  Health status and longevity are shaped by the historical circumstances and 
social environments that we live in.   This study offers three innovative and significant 
contributions to the understanding of biological and environmental determinants of aging 
by (1) disentangling the biological and temporal sources of trends in cancer incidence 
among the elderly, (2) investigating the possible social and physiological effects of 
fertility history on comorbidity trajectories after age 65, and (3) studying heterogeneity in 
the heritable contributions to variation in longevity across early life family and social 
environments.    
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AGING AND LONGEVITY: THE PAST AND FUTURE TRENDS 
 
Introduction 
Demographers, biologists, social scientists, geneticists, historians, and other 
scientists have long embarked on the quest of uncovering the secrets of healthy aging and 
longevity.  While the fascination with longevity is not unique to this time period, the 
rapid changes in life expectancy and population structure over the past century have 
elevated the importance of understanding determinants of healthy aging and longevity. 
The mortality profiles of the developed countries have especially undergone fundamental 
transformations over the past century.  Life-expectancy in these populations has increased 
linearly by approximately 3 months per year for the past 160 years (Oeppen & Vaupel, 
2002).  Historically, these improvements have been largely due to improvements in 
survival in infancy and childhood.  While less recognized, death rates at older ages have 
also greatly improved over the last half of the 20
th
 century (Vaupel et al., 1998).   
Significant declines in fertility during the demographic transition combined with 
gains in life expectancy past age 65 have led to population aging (rising proportions of 
the population age 65 and older) and increased levels of old-age dependency.  These 




population age 65 years and older will increase from 12.3% in 2000 to 21.1% in 2050 in 
the United States (Uhlenberg, 2005).  The oldest old population (ages 85+) is projected to 
more than triple from its current estimate of 5.7 million to 24 million by 2050 (Vincent, 
Velkoff, & Bureau, 2010), making it the fastest growing segment of the population.   The 
rising proportions of the population above the age of 65, combined with increases in life 
expectancy and current trends in mortality decline in the oldest age categories, have made 
the determinants of longevity and healthy aging critical to understanding population 
health.  Aging research is an extremely important domain of population health, and its 
significance will increase as the proportion of the population age 65 and older continues 
to rise.   
The biological and social factors that determine healthy aging and longevity, and 
their interaction, are still not well understood.  In the past, misconceptions about the 
limits of life-span have led demographers to underestimate the rate of decline in old-age 
mortality (Uhlenberg, 2005).  Current  projections suggest that if the present gains in life 
expectancy continue, more than half of individuals born after 2000 will live to see their 
100
th
 birthday (Christensen, Doblhammer, Rau, & Vaupel, 2009).  Unfortunately, such 
projections ignore the complex interactions of social and biological factors that determine 
mortality.   
This dissertation improves upon previous research by investigating the influence 
of the social environment, biology, and heritability throughout the life course on healthy 
aging and longevity.  The studies presented in this manuscript seek to disentangle the 
biological and temporal sources of trends in cancer incidence, investigate the possible 
social and physiological effects of fertility history on comorbidity trajectories after age 




longevity across early life family and social environments.  A fuller understanding of 
heterogeneity in patterns of aging and the factors throughout the life course that shape 
them will lead to more accurate population prediction, identify at risk population that 
may benefit from more effective public health interventions, and characterize the process 
of aging in a diverse population.   
A rigorous investigation into biological and social causes of healthy aging and 
longevity at advanced ages requires a theoretical framework capable of assimilating 
theories from multiple disciplines.  Biodemography provides a multidisciplinary 
synthesis of biological, evolutionary, social science, ecological, life history and 
demographic theories and is primed to answer a range of questions including those about 
both how and why humans age (Vasunilashorn & Crimmins, 2008).  Over the past few 
decades, demographers have broadened the focus of work in the demography of aging 
from a population aging perspective (i.e., measures of change in population age 
structure), to include a perspective that integrates health and biological explanations with 
traditional demographic and social theories of aging to explain variations in health and 
mortality within and between populations (Olshansky, Carnes, & Brody, 2002; Siegel, 
2011; Vasunilashorn & Crimmins, 2008).   
 
The Biodemographic Perspective of Aging 
As developed countries began to recognize most of the longevity gains to be 
secured were achieved by improving infant and childhood mortality, questions began to 
surface about how much improvement can be made in mortality rates at the other end of 
the spectrum, what proportion of mortality at these ages is biologically determined, and 




be realized (Carnes & Olshansky, 2007; Vaupel et al., 1998).  “Aging, Natural Death, and 
the Compression of Morbidity,” an article published by James Fries (1980), resulted in  a 
lively debate about the limits of life-span within the field of demography, with some 
arguing that physiological decay was innately programmed (Fries, 1980), others 
suggesting that old age is not biologically determined but there are practical limits that 
will make steady improvements difficult (Carnes & Olshansky, 2007), and a third group 
projecting linear increases in life expectancy for the foreseeable future (Vaupel et al., 
1998).   
This debate is centered on a pivotal question; are we biologically programmed to 
die?    Even under ideal conditions, there is a progressive increase in age-specific death 
rates and senescence (Carey & Judge, 2001).  Theories aimed at answering why we 
senesce and inevitably die can be classified into two broad categories: thermodynamic 
and biological evolutionary theories of aging (Austad, 2001).  Thermodynamic theories 
implicitly or explicitly claim that aging is the inescapable consequence of the physical 
nature of matter. These theories arrive at the conclusion that senescence is a genetically 
programmed rate of decay, the natural consequence of approaching one’s maximum 
possible life-span (Fries, 1980).  Biological evolution theories explain senescence in 
terms of selection forces acting on life history traits (Kirkwood & Rose, 1991).  
Reliability theories of aging, optimization models, and nonadaptive mutation models (see 
Table 1.1 for a more detailed description of these theories) all describe senescence as a 
byproduct of evolution and not an innately programmed switch that is common to all 
organisms. 
The compression of morbidity hypothesis (Fries, 1980) argues that morbidity and 




primary prevention such as maintaining a healthy lifestyle.  Principally, he argued that 
the rectangularization of the survival curve would be accompanied by an increase in age 
at onset for chronic disease and disability which, in turn, compresses the time spent in a 
diseased or disabled state.  Others argued the failure of success hypothesis, which 
suggests that improved survival of frail individuals will lead to increases in disease later 
in life (Gruenberg, 1977; Kramer, 1980).   Not only did these hypotheses spark interest in 
determinants of life-span, but they also led to debate about heterogeneity in patterns of 
aging, whether increased life expectancy indicated increased healthy life expectancy, and 
whether centenarians escaped major age-related diseases.   
The evidence consistent with morbidity compression is still uncertain.  Most 
evidence for individuals younger than 85 suggests there has been a postponement in 
disease and disability over time, but little is known about trends in the population age 
85+.  This is largely because health data for this group of the population is not as readily 
available (Boscoe, 2008).  Although there are some studies of disease in centenarians that 
suggest that a proportion of these exceptionally long-lived individuals delay or escape 
disease, there is still considerable variation in disease experience (Andersen, Sebastiani, 
Dworkis, Feldman, & Perls, 2012; Evert, Lawler, Bogan, & Perls, 2003).  Uncertainty of 
the expected trends in morbidity with age coupled with the fiscal demands of the 
Medicare program have made the question of morbidity patterns above age 65 a central 
biodemographic question.  While the association between morbidity and mortality is 
complex and varies across populations and environments (Siegel, 2011), most 
classifications of morbidity (for example, heart disease and dementia) lead to higher rates 




of major morbid conditions and how these factors change over time can yield better 
predictions of morbidity and mortality trends at advanced ages.   
In his 1980 paper, Fries made a prediction: life expectancy would not exceed 85 
years. This prediction was quashed in 2007, when the average life-expectancy for 
Japanese women reached 86 years (Christensen et al., 2009).  The continued steady rise 
in life expectancy suggests that if there is a fixed limit, we have not yet reached it.  While 
limits in life expectancy suggested by those supporting a biological limit to life-span have 
been surpassed, Jean Calment’s documented life-span of 122 years has yet to be broken.   
Therefore two questions still remain: are we biologically programmed to die, and what 
patterns of disease can we expect to see if life expectancy continues to rise?  While these 
questions have important implications for future population projections, we cannot arrive 
at a suitable answer unless we consider another component that has been largely ignored 
up to this point in the discussion: the relationship between social context, healthy aging, 
and longevity.   
Aging does not take place in isolation.  It is heavily influenced by our 
environments.  Understanding the interplay between social context and biological factors 
is imperative to understanding and predicting future trends in aging and mortality. Social 
and historical context must be considered when determining morbidity and mortality 
trends within a population.  For example, studies have suggested that age, period, and 
cohort factors are all important factors that affect population trends in mortality (Preston 
& Wang, 2006; Yang, 2008).  Mortality at ages 80 years and above has fallen at an 
unprecedented pace since the 1950s (Kannisto, 1996), but old-age mortality in the United 
States has stagnated since 1980 (Rau, Soroko, Jasilionis, & Vaupel, 2008).  Other authors 




considering the social and historical context which shapes it, and have suggested that the 
rapid increase in obesity may lead to declines in life expectancy in the near future (Jay 
Olshansky et al., 2005; Reither, Olshansky, & Yang, 2011).  Accurate predictions of 
health and mortality of the aged population requires an approach that crosses disciplinary 
boundaries and integrates biological and sociological concepts.   
Biodemographers embrace the view that sociological context affects healthy 
aging and longevity, for not only do social theories explain the demographic transition 
but the central idea that health and longevity is socially patterned is deeply rooted in the 
sociological tradition (Berkman & Syme, 1979; House, Landis, & Umberson, 1988; Link 
& Phelan, 1995; Wen, Browning, & Cagney, 2003; Wise, 2003).  But by integrating 
biological theories and measures with sociological theories, the field of biodemography 
has great potential for making contributions that will improve public health by 
considering how social, economic, behavioral, and psychological conditions “get under 
the skin” to cause health problems (Crimmins & Seeman, 2004; Robine, 2006; 
Vasunilashorn & Crimmins, 2008).  It has also become evident that proximate social 
circumstances alone cannot explain heterogeneity in aging and the experiences across the 
life course play an important role.   
 
Biology, the Life Course, and Aging 
Healthy aging and longevity cannot be understood by restricting analysis to a 
single life stage because aging is a lifelong process.  The life course perspective places 
importance on both the historical and demographic parameters related to aging and 
longevity, as well as the biological, social and psychological factors that influence aging 




and pathway) mechanisms throughout the life course (S. H. Preston, Hill, & Drevenstedt, 
1998; Settersten, 2003).  Simply put, it requires the researcher to consider how risk is 
shaped throughout the life course, beginning with biological development in utero. 
Genetic influences have been cited as perhaps the earliest biological factor 
contributing to later life morbidity and mortality (Smith, Hanson, & Zimmer, 2012).  The 
two types of longevity genes, gerontogenes and longevity-assurance genes, can be used to 
describe the effects of genes on longevity  (Christensen, Johnson, & Vaupel, 2006; 
Sebastiani et al., 2012).  Gerontogenes negatively affect longevity, thus life-span 
increases when their expression is blocked.  Longevity assurance genes lead to a 
phenotypic expression of longer life-span and therefore longevity decreases when their 
expression is blocked.  Thus, genetic endowments may either be protective, as in the case 
of familial excess longevity (Smith, Mineau, Garibotti, & Kerber, 2009), or detrimental, 
as in the case of certain apolipoprotein E (APOE) alleles (Ewbank, 2004).  
Genes are fixed at birth, but is their expression?  To answer this question, 
comparisons of monozygotic and dizygotic twins have been made to compare life spans 
while holding the childhood environment constant.  These studies estimate heritability of 
life-expectancy to be 25% (Herskind et al., 1996; Skytthe et al., 2003).  Twin studies 
have also revealed the variable nature of gene expression with age (Fraga et al., 2005; 
Petronis et al., 2003) and it has been suggested that epigenetic mechanisms cause 
individuals with the same genotype to have increasingly divergent phenotypes with age.   
An individual’s genotype is inherited at birth and can be considered immutable.  
However, gene expression is malleable because it is influenced by the environment 
through the epigenome.  Epigenetic modifications can be defined as “the sum of heritable 




Dato, Bellizzi, Rose, & Passarino, 2012).  Epigenetics is a bridge between genetics and 
environment and may explain a portion of the variation in the rate of aging and longevity.  
It is one of several possible biological mechanisms that allow social circumstances to get 
“under the skin,” and epigenetic modifications have the propensity to persist across 
subsequent generations (Feinberg, 2007).   Differences in community and family 
environments may affect the epigenetic regulation of gene expression and lead to 
variation in the longevity phenotype.  Recent studies suggest a relationship between 
strength of genetic correlations and the quality and variability of an environment 
(Charmantier & Garant, 2005).  There may also be epigenetic changes in response to 
individual social experiences throughout the life course (Champagne, 2010).   Does the 
social environment throughout the life course shape later life health and mortality? 
Events throughout the life course can alter physiological functioning and affect 
later life health and longevity.  Early life conditions have been shown to be significantly 
correlated with adult mortality for individuals and cohorts (Abel & Kruger, 2010; Barker, 
1995; Doblhammer & Vaupel, 2001; Eriksson, Forsén, Tuomilehto, Osmond, & Barker, 
2001).  The fetal origins hypothesis and inflammation hypothesis are two theories that 
have been used to explain the biological programming of an individual early in life.  
According to the fetal origins hypothesis, individuals exposed to adverse conditions in 
utero may have altered morbidity and mortality trajectories due to altered development of 
key organ systems or epigenetic modifications during gestation.  The inflammation 
hypothesis argues that exposures to infectious disease during infancy and childhood 
result in altered morbidity and mortality trajectories in adulthood  (Crimmins & Finch, 
2006; Finch & Crimmins, 2004).  McDade, Rutherford, Adair, and Kuzawa (2010) have 




exposure to infectious disease and inflammation in adulthood, arguing that exposure to 
infectious diseases are necessary for healthy development of the immune system.   
Early life conditions may also be indirectly associated with morbidity and 
mortality outcomes through correlated environments, cumulative processes, health 
selection, and mortality selection.  Indirect associations through correlated environments 
are based on the principle of continuity of the life course and that one’s environment 
during childhood is the same or similar to one’s adult environment.  Selection 
mechanisms may also lead to an indirect association between early life circumstances and 
later life health outcomes.  The health selection hypothesis argues that illness has social 
consequences that may lead to poor socioeconomic status (SES) later in life and that it 
may be the more proximate exposure to poor SES that is responsible for the observed 
association between early life conditions and later life health (Montez & Hayward, 2011).  
This continuity may lead to erroneously attributing the observed outcome to early life 
conditions, when it is the proximate environment that is leading to adverse health 
outcomes.  Alternatively, genetic heterogeneity in the population may lead to differential 
mortality selection; with those at the highest risk, the frail, being culled from the 
population early leading to a population with a disproportionate representation of robust 
individuals at older ages (Elo & Preston, 1992; Hawkes, Smith, & Blevins, 2012).    
Related to this argument is the cumulative advantage/disadvantage hypothesis, 
which argues that early life events can set into motion a trajectory where 
advantage/disadvantage is accumulated throughout the life course (O'Rand & Hamil-
Luker, 2005).  Sequential exposures to adverse environments may lead to excess stress or 
exposure to chronic stress that leads to increased risk for disease later in life.  




inequalities are created through the accumulation of advantage/disadvantage across the 
life course (Elder & Giele, 2009).  Cumulative disadvantage can be set into motion by 
early life events or situations that lead to structural constraints throughout the life course 
(O'Rand & Hamil-Luker, 2005).   
Physiological changes to the body in response to social conditions are not 
constrained to critical or sensitive periods of development.  These changes can occur in 
response to prolonged exposure to stress throughout the life course.  Allostatis, the ability 
to achieve stability through change, is maintained in the body through the autonomic 
nervous system, hypothalamic-pituitary-adrenal (HPA) axis, and the cardiovascular, 
metabolic, and immune systems (McEwen, 1998).  Allostatic load describes a process 
through which exposure to chronic stress throughout the life course can lead to wear and 
tear in these systems and lead to poor health in adulthood (Geronimus, 1992; McEwen, 
1998), and these effects can be attenuated or accentuated by an individual’s access to 
economic, social, or personal resources (Elder & Giele, 2009).  Under this hypothesis, 
individuals that are continually exposed to stress may experience physiological 
deterioration of key systems that lead to chronic disease later in life.  Recent epigenetic 
research has also shown that epigenetic modifications occur across the life span 
(Champagne, 2010; Montesanto et al., 2012; Shanahan & Hofer, 2011).  While more 
research needs to be done, it has been suggested that epigenetic changes during the aging 
process may directly contribute to malignant transformation of cells (Fraga, 2009). 
Placing human lives in context is fundamental to life course research.  The life 
course perspective promotes the view that social and physical environments vary by time 
and space and underscores the multiple layers of human experience.  It also highlights the 




social or ecological environment are dependent upon the age of an individual and are 
unique to a group of people born during the same time period or birth cohort.  
Biodemography adds to this concept by recognizing that we live in a very different 
environment from the one in which our life history evolved.  Genetic, social, and 
economic history and environments play an important role in shaping health and disease 
patterns across populations and communities.   
Birth cohorts are a measure of the social forces that shape health throughout the 
life course (Keyes, Utz, Robinson, & Li, 2010).   They vary in size, demographics, social 
norms, prevalence of infectious disease, food availability, level of medical knowledge, 
education, occupation, urbanization, etc., making each cohort unique.  For example, 
changes in smoking patterns or other environmental exposures over time may lead to 
cohort specific trends in cancer incidence.  They have been regarded as fundamental units 
of social organization (Easterlin, 1998; Elder, 1999).  Finch and Crimmins’ cohort 
morbidity phenotype hypothesis suggests that differential exposure to infectious diseases 
during childhood will lead to cohort differences in old age morbidity and mortality 
(Crimmins & Finch, 2006; Finch & Crimmins, 2004).  While cohort effects have proven 
important for a number of different outcomes related to aging and longevity (Chen, Yang, 
& Liu, 2010; Yang, 2008), some researchers are skeptical of the life course researcher’s 
fascination with historical time (Fry, 2003), and others have argued that period factors 
play a more important role in determining mortality rates in old age (Gagnon & Mazan, 
2009; Kannisto, 1996).   
The life course perspective facilitates questions about possible pathways to later 
life health and potential confounding factors.  The integration of biodemographic 




heritability of longevity may be altered by events throughout the life course. Biological, 
social, and psychological theories of development will be integrated in an attempt to 
create a more complete view of how later life health is shaped by a lifetime of past 
exposures. 
Population aging is one of the greatest societal challenges of the next 50 years 
(Kalache, Barreto, & Keller, 2005; Schoeni & Ofstedal, 2010).  There are both social and 
economic consequences of population aging.  Accurate projections of how the elderly 
population ages has policy implications for forecasting Social Security and Medicare 
expenditures and predicting the costs of aging nationally and globally.  The increase in 
the proportion of the population over the age of 65 will also change the types of illnesses 
and prevalent diseases in the population, affecting the types of medical services needed.  
The projected increase in the proportion of the population at advanced ages has grave 
implications for public pension programs, health care, and old age dependency.  A greater 
understanding of the sociological, biological, and heritable determinants of aging and 
longevity is essential to maintaining a healthy population and economy.  
  
The Determinants of Aging and Longevity 
 Perhaps the best way to elucidate mechanisms of aging and longevity is to study 
the heterogeneity in morbidity and longevity and determine what factors contributed to 
observed differences.  This research contributes to the scientific understanding of aging 
and longevity patterns and the factors throughout the life course that influence them.  
Understanding the sources of variation in patterns of aging and longevity is important for 




from public health interventions, and characterizing the process of aging in a diverse 
population.  
Cancer was the second leading cause of death for individuals aged 65 and older in 
the United States in 2010 (Miniño & Murphy, 2011), making it an essential component to 
the study of aging and morbidity.  Studies that do not account for changes in the 
environment, diet, health behaviors, and screening and diagnostic practices are ignoring 
the multifaceted determinants of cancer and may be inadvertently attributing temporal 
determinates of observed trends to biological mechanisms.  Failing to account for cohort 
and period specific trends may confound the true age trajectory of cancer in this 
population.  Chapter 2 disentangles these trends for individuals age 65 to 99 using Utah 
cancer incidence rates from 1963 to 2002, which lend better understanding to the true 
age-specific trends in cancer incidence, including the previously understudied oldest old 
age group (85+).  It is important to account for cohort variations in aging and longevity in 
order to avoid misattributing patterns caused by historical circumstances to biological 
changes associated with age.  Disentangling age, period, and cohort effects for major 
health conditions in the oldest old categories will allow for more definitive assertions 
about the possible causes of mortality deceleration and increased accuracy in forecasting 
of future trends used to predict the fiscal burdens of an aging population.   
The pathology of chronic disease is multifaceted, determined by genetic profiles, 
biological and physiological development, and the social environment, with the strength 
and relative importance of each of these factors varying throughout the life course.   
Understanding longitudinal patterns of morbidity after age 65 is important to 




predicts the observed patterns.  Are measures of fertility and reproductive health 
associated with morbidity profiles later in life?   
Biological, evolutionary, and social theories all predict a relationship between 
fertility and later life morbidity trajectories.  Chapter 3 examines the role of parity, young 
age at first birth, age at last birth, interbirth intervals, infant death, multiple births (twins), 
marital status at time of birth, birth weight of offspring, and preterm births for both men 
and women on disease progression after age 65.  This study utilizes Centers for Medicare 
(CMS) data spanning from 1992 – 2009 linked to the Utah Population Database, which is 
a rich source of longitudinal data.  Studying the effects of fertility history on men and 
women at several stages in the aging process will lend clues to biological, evolutionary, 
and social mechanisms that may lead to the observed outcomes.   
For a more complete understanding of population heterogeneity in life-span and 
the forces behind it, one must not only understand the average contribution of genes and 
environment within a population toward explaining variation in adult mortality, but 
uncover the factors that influence patterns of variation within the population.  While there 
is strong evidence supporting a genetic component to longevity, surprisingly, its size and 
relative importance is poorly understood.  Longevity is a complex trait, determined by a 
multiplicity of genetic and environmental factors, with each factor contributing a 
potentially small amount to phenotypic variation.   This phenotypic variation can be 
partitioned into genetic and environmental variation.  Chapter 4 tests for heterogeneity in 
the heritability of longevity across several early and midlife environments and explores 
the possibility of gene-environment interactions (GxE).  By examining sources of 
variation in heritability estimates, we can illuminate factors that modify the expression of 




environmental determinants of aging and mortality, and how they interact, can allow for 
the identification of sources of variation in morbidity and mortality and improve 
predictions of morbidity and mortality for future generations. 
The final chapter provides a short summary of the findings from the studies 
presented in Chapters 2-3.  These studies provide insight into patterns and processes of 
aging and highlight important factors to consider as the proportion of the population aged 
65 years and older continues to grow.  This chapter also gives direction for future 
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 CHAPTER 2  
 
AN AGE-PERIOD-COHORT ANALYSIS OF CANCER INCIDENCE  
AMONG THE OLDEST OLD
1
 
   
 
Abstract 
Disentangling age, period, and cohort effects for major health conditions in the 
oldest old categories will lead to better population projections of morbidity and mortality.  
Data from the Utah Cancer Registry (UCR), the U.S. Census, the National Center for 
Health Statistics (NCHS) and the National Cancer Institute’s Surveillence Epidemiology 
and End Results (SEER) program are used to generate age-specific estimates of cancer 
incidence for ages 65–99 from 1973–2002 for Utah.  Age-period-cohort (APC) analyses 
are used to describe the simultaneous effects of age, period and cohort on cancer 
incidence rates in an attempt to understand the population dynamics underlying their 
patterns. Our results show increasing cancer incidence rates up to the 85–89 age group  
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followed by declines for ages 90–99 net of period and cohort effects. We find significant 
period and cohort effects, suggesting the role of environmental mechanisms in cancer 
incidence trends between the ages of 85 and 100. 
 
Introduction 
The demographic profile of the United States is changing, with proportionately 
more individuals surviving to very old ages.  The oldest old population (ages 85+) is 
projected to more than triple from its current estimate of 5.7 million to 24 million by 
2050 (Vincent, Velkoff, & Bureau, 2010), making it the fastest growing segment of the 
population.  This substantial growth makes the study of morbidity and mortality for this 
age group increasingly important. 
The deceleration of all-site mortality at advanced ages is a commonly observed 
phenomenon in both humans and animal species (Horiuchi & Wilmoth, 1998; Vaupel et 
al., 1998) andcan be explained at the macrolevel due to changes in population 
composition  (e.g., heterogeneity hypothesis) or at the microlevel attributable to 
physiological changes related to aging, (e.g., individual risk hypothesis).  Alternatively, 
this observed trend may be the result of age misreporting in the oldest age categories, 
heterogeneous birth cohorts, and inaccurate measures of mortality in the oldest age 
categories (Gavrilov & Gavrilova, 2011).  While the association between morbidity and 
mortality is complex (Siegel, 2011), studying patterns of human morbidity gives insight 
into the age related changes in morbidity and mortality (Svetlana V. Ukraintseva & 
Yashin, 2001), particularly for prevalent diseases such as cancer.  A more complete 
understanding of the determinates of cancer and how these factors change over time can 




Disentangling age, period, and cohort effects for major health conditions in the oldest old 
categories will allow for more definitive assertions about the possible causes of mortality 
deceleration and increased accuracy in forecasting of future trends used to predict the 
fiscal burdens of an aging population.   
Little is known about age-specific disease incidence and prevalence among the 
oldest old, including cancer (Boscoe, 2008).  In 2000, the oldest old age group accounted 
for 8% of all incident cancer cases, and this number is projected to rise to 17% by 2050 
assuming current incidence rates continue (Hayat, Howlader, Reichman, & Edwards, 
2007).    Unfortunately, traditional surveillance methods limit our ability to examine age-
specific cancer incidence in this subpopulation.  The National Cancer Institute’s 
Surveillance Epidemiology and End Results (SEER) program aggregates cancer 
incidence information for the 85+ age group, making it difficult to study cancer trends in 
the oldest old. 
The few studies that examine cancer incidence trends after age 85 present 
evidence of a deceleration in cancer incidence, prevalence, and mortality at the oldest 
ages. (C. Harding, Pompei, Lee, & Wilson, 2008; Kaplan & Saltzstein, 2005; Saltzstein, 
Behling, & Baergen, 1998).   While patterns for different time periods are presented for 
the oldest old population, the literature is limited with regard to analyzing change in the 
trends over time.  Time is a dimension of context, or the structure of the physical and 
social environment related to a specific period or historical experiences unique to a birth 
cohort, that influences health (Suzuki, 2012).  Recent studies have shown the importance 
of considering not only the effect of age, but also the role of period and cohort 
experiences when studying health outcomes (Reither, Hauser, & Yang, 2009; Yang, 




considered because there may be different biological and social determinants of cancer 
for men and women that vary by site (Yancik, 2005).  This study aims to contribute to the 
current literature by examining age, period, and cohort trends in cancer incidence from 
1973 to 2002 for ages 65 to 99 using data from the Utah Cancer Registry (UCR), the 
National Cancer Institute’s Surveillance, Epidemiology and End-Results Program 
(SEER), the decennial Census, and the National Center for Health Statistics (NCHS).   
 
Background 
Disentangling Age, Period, and Cohort Effects 
Age effects are generally understood to represent the biological characteristics of 
an individual.  Cross-sectional studies of all-site cancer incidence and death rates show 
that rates generally increase with age, peaking between ages 75 and 85, and then 
plateauing before declining in advanced ages (Andersen et al., 2005; Arbeev, 
Ukraintseva, Arbeeva, & Yashin, 2005a; C. Harding et al., 2008; Saltzstein et al., 1998; 
Stanta, 1997).  However, many of these studies can only offer limited conclusions about 
cancer trends in the oldest old because they aggregated ages 85+, examined a single 
period, or failed to consider period and cohort influences.   
Period effects can be described as the social and environmental context that 
modifies risk for all individuals in a population at a specific point in time. Changes in 
cancer screening technology may affect cancer incidence rates at all ages.  
Mammography screening became widespread during the 1980s, leading to an increase in 
incident female breast cancer diagnoses over the age of 65 (Edwards et al., 2002); colon 
cancer cases increased during the 1990s as a result of changes in colorectal screening 




for males over the age of 65 between 1988 and 1992 due to the introduction of  the 
Prostate-Specific Antigen (PSA) screening test for prostate cancer (Edwards et al., 2002). 
Changes in health care policy may also create period effects in cancer incidence.  For 
example, Medicare began covering mammographies in 1991(Kelaher & Stellman, 2000) 
and colon cancer screening in 2001 (Berkowitz, Hawkins, Peipins, White, & Nadel, 
2008).  Thus, the introduction of new diagnostic tools into the health care market, and 
changes in screening policies and medical practices have an impact on incidence rates 
over time.     
Cohort effects describe the social or ecological environment unique to individuals 
born in the same group of years.  Epidemiologists often describe cohort effects as the 
interaction between age and period, while sociologists conceptualize them as a measure 
of social forces that shape health throughout the life course (Keyes, Utz, Robinson, & Li, 
2010).  For example, changes in smoking patterns or other environmental exposures over 
time may lead to cohort specific trends in cancer incidence.  Improvement in cancer 
screening technology may also have differential effects by birth cohort because the 
benefit is not equally shared amongst all ages.  For example, the Agency for Healthcare 
Research and Quality does not recommend routine colonoscopies after the age of 75 
(National Guideline), and questions about the efficacy of cancer screening for the oldest 
old have also been raised (Østbye, Greenberg, Taylor, & Lee, 2003).  In addition to the 
age-based bias created by cancer screening recommendations, cancer incidence rates for 
these ages may be subject to detection bias because screening is difficult for frail 
individuals (Ukraintseva & Yashin, 2003).  A more comprehensive understanding of the 




essential for developing effective screening and treatment recommendations for this 
population. 
Cross-sectional analyses show a decline in cancer incidence for the oldest old that 
is similar for men and women.  However, results from previous studies indicate that the 
shape, height, and peak of age-specific incidence curves are sensitive to both historical 
period, cancer site, and study (C. Harding et al., 2008; Kaplan & Saltzstein, 2005; 
Saltzstein et al., 1998).  If cancer incidence rates in this age group were based strictly on 
the biological factors contributing to aging, one would expect to see consistency in age-
specific rates over multiple periods of study.  However, the fluctuation in rates is 
evidence of the influence of external factors, related to period and birth cohort, 
contributing to cancer incidence.  Treating the pattern of decline as an effect of aging 
neglects evidence of a social and ecological context that may alter age-specific trends and 
ignores the multifaceted determinates of cancer risk (Kaplan & Saltzstein, 2005; Stanta, 
1997).  Using a comprehensive approach that studies cancer trends over time and 
accounts for period and cohort effects will allow for a more accurate depiction of the age-
specific trends in cancer incidence.   
 
Aging and Cancer 
 Disagreement exists among theories explaining the relationship between cancer 
and aging and the observed decline in cancer incidence in the oldest old (Anisimov, 
2003; Ukraintseva & Yashin, 2003).  These controversies are similar to those surrounding 
mortality deceleration and may prove useful for understanding the mechanisms driving 




There are three prevailing hypothesis explaining mortality deceleration (Gavrilov 
& Gavrilova, 2011; Horiuchi & Wilmoth, 1998).  The first hypothesis asserts that the 
observed patterns of mortality deceleration are the result of age-misreporting and/or 
model misspecification (Gavrilov & Gavrilova, 2011), thereby suggesting that mortality 
does not decelerate with age, but is a statistical artifact.  The other two hypotheses are the 
heterogeneity hypothesis and the individual risk hypothesis (Horiuchi & Wilmoth, 1998).  
These hypotheses lead to similar predictions about age related changes in cancer 
incidence.   
  
Theories Predicting that an Individual’s Cancer Risk Increases  
with Age (Deceleration is an Artifact)  
The multistage theory predicts that cancer incidence rates should increase with 
age because the neoplastic transformation of cells occurs through several successive steps 
(Anisimov, 2003; Armitage & Doll, 1954).  This framework describes cancer incidence 
as a power function of exposure time rather than age because cancer is caused by the dose 
and duration of carcinogenic exposure over a person’s lifetime (Anisimov, 2003; 
Ukraintseva & Yashin, 2003).  Under this scheme, the path to cancer is step-wise and 
irreversible, with each step leading to an increased probability of malignant 
transformation with exposure time and therefore age.  However, exposure risks between 
cohorts may vary, giving rise to different patterns of age related incidence between birth 
cohorts.   
Physiological mechanisms may also explain increases of cancer incidence with 
age.  The cancer-longevity tradeoff hypothesis suggests that the cost of living a long life 




a decline in immune surveillance, loss in tumor suppressor function, and mutation 
accumulation are additional factors that have been cited as possible mechanisms leading 
to the increasing rates of cancer incidence with age (Anisimov, 2003; Campisi, 2003; 
Ukraintseva & Yashin, 2003).  Many of these factors may be modified by environmental 
exposures and therefore the context of time. Factors such as diet, smoking, exposure to 
infectious disease (Ukraintseva & Yashin, 2003); and environmental interventions such 
as exercise, social support, and screening practices, may make age specific trends 
sensitive to temporal context.   
 
 
Theories Predicting that an Individual’s Cancer Risk Declines  
with Age (Individual Risk Hypothesis)   
The individual risk hypothesis argues that the deceleration in morbidity and 
mortality rates at older ages can be explained in terms of physiology, evolution, and 
health behaviors (Horiuchi & Wilmoth, 1998; Vaupel et al., 1998).  Although 
physiological mechanisms have been used to explain increasing cancer incidence with 
age, they may also predict the opposite—that cancer incidence in the oldest old age 
categories decelerate and decline.  Physiological changes can contribute to the decline in 
cancer incidence in the oldest old through age-related declines in rates of cellular 
metabolism, suppression of tumor generation, and increased cellular doubling time 
(Ukraintseva & Yashin, 2003).   
Natural selection may also affect age related declines in cancer incidence.  
Mutation accumulation theory argues that age-related declines in the force of natural 
selection may result in an accumulation of mutations that result in an increase in 




in the oldest age categories (Horiuchi & Wilmoth, 1998).  In addition, mechanisms which 
may protect against cancer may increase longevity, suggesting that individuals in the 
oldest old age groups may be less susceptible to cancer (Campisi, 2003).   
Variation in age-related health behaviors could also explain a decrease in cancer 
incidence in the oldest old age groups.  Cancer trends periodically shift due to changes in 
screening procedures and recommendations, but these period effects may not be equal 
across all ages.  Routine cancer screening has increased in the general population 
(Edwards et al., 2002); however, studies have suggested that there is a decrease in 
surveillance for the oldest old and an increase in misdiagnosed or unreported tumors 
(Kaplan & Saltzstein, 2005; Stanta, 1997).  These factors may lead to cohort specific 
trends in cancer incidence. 
 
Population Heterogeneity Leads to Decreased Rates of Cancer  
Incidence in the Oldest Old (Heterogeneity Hypothesis).  
 Population heterogeneity, differential risk patterns within a population, can be the 
result of both within and between cohort differences, making the context of cohort an 
important consideration.  Within a single cohort heterogeneity can occur because the 
force of mortality may decrease at advanced ages (Horiuchi & Wilmoth, 1998), pointing 
researchers to a selection hypothesis to explain the decline.  According to these 
hypotheses, there is differential selection in a heterogeneous population with the frail 
being selected out of the population at earlier ages (Hawkes, Smith, & Blevins, 2012).  
Individuals culled from the population may have a genetic or environmental 
predisposition to cancer, leaving their robust counterparts to survive to the oldest ages 




deleterious mutations, such as the BRCA1 mutation, have elevated cancer mortality rates 
as compared to the general population, making them less likely to survive to advanced 
ages (K. R. Smith, Hanson, Mineau, & Buys, 2011).   
Population heterogeneity can also arise because different cohorts have 
experienced different mortality schedules, environmental exposures, public health 
initiatives (such as antismoking campaigns), and cancer screening recommendations.  It 
has been suggested that the multistage theory is correct, and a plateau or decline in cancer 
incidence rates at old ages may reflect period and cohort trends (Yang, 2008).  If 
exposure to different carcinogens such as tobacco smoke, changes in diet, or other 
environmental carcinogens, fluctuates over time the deceleration in incidence rates at the 
oldest ages may reflect these changes rather than somatic aging per se.  A decline or 
deceleration in cancer trends in old ages may be a function of cohort experiences such as 
screening practices or health behaviors for this age group.   
Understanding the relationship between cancer incidence and age will not only 
improve future predictions of cancer incidence, it will help U.S. understand the 
mechanisms leading to mortality deceleration in the oldest old population.  Cancer trends 
for the oldest old population are understudied because cancer incidence rates are 
historically aggregated for all 85+ individuals (Boscoe, 2008).  This study aims to 
improve upon current literature by examining temporal trends of cancer incidence from 










This study uses data for the state of Utah from 1973 to 2002 collected from the 
Utah Cancer Registry (UCR), the National Cancer Institute’s Surveillance, Epidemiology 
and End-Results Program (SEER), the decennial Census, and the National Center for 
Health Statistics (NCHS).  Cancer incidence cases and the U.S. Census Bureau’s 
Population Estimates for the state of Utah for ages 65 to 84 were obtained from 
SEER*Stat software (2010; 2012).  Statewide cancer data are collected by the UCR as 
part of routine cancer surveillance for the Utah Department of Health and the National 
Cancer Institute’s SEER Program.  Cancer cases are reported to the UCR through health 
service providers and death certificates on which cancer is listed as a cause of death.  Site 
and histology are coded according to the International Classification of Diseases for 
Oncology (ICD-O) at the time of diagnosis (Stroup, Dibble, & Harrell, 2008). 
 Age-specific incidence counts for ages 85 to 99 are not reported by the SEER 
program.  At these ages, age misstatement is a widely recognized problem, making 
population estimates less reliable (Boscoe, 2008).  Tabulated incidence data by year and 
age were provided by the UCR.  Intercensal population estimates were calculated via the 
cohort-component and extinct-cohort methods using decennial data from the U.S. Census 
Bureau and mortality data from the National Center for Health Statistics (Shryock, 
Siegel, & Larmon, 1980).  The cohort-component method starts with the cohort 
populations reported in the decennial census and then subtracts deaths to estimate 
population sizes.  The use of census and death certificate data has been criticized because 
upward age-misstatement can lead to a downward bias of incidence rates for this 




occurrence with error rates improving over time (Boscoe, 2008; Hill, Preston, & 
Rosenwaike, 2000; SH Preston, Stewart, & Elo, 1999).  Data collection issues have also 
caused errors in population estimates for the oldest old (Siegel & Passel, 1976).  The 
extinct-cohort method is an alternative method of calculating population counts. It relies 
on death certificate data and is thought to be more reliable when cohorts are close to 
extinction because it is less subject to bias caused by age misreporting.  Rates from both 
methods were compared and we found that when cohorts are farther from extinction 
estimates using the extinct-cohort method become less reliable.  The cohort component 
method was selected as the basis for the final models.  A detailed description of the 
methods and comparison between rates will be presented in an article by Rudy et al. and 
can be provided upon request.  The final data set consisted of population level cancer 
incidence counts (numerators) and cohort-component population estimates 




 Sex- and site-specific cancer incidence trends from 1973-2002 for ages 65 to 99 
for the state of Utah were selected for analysis.  There were no incidence cases above age 
100 from 1973 – 1982 and 1988 – 1997 for males and 1973 – 1977 for females; therefore 
we did not include this age category in the analysis.  Cancer incidence rates were 
calculated as the ratio of incident cases to person years of exposure.  Age-specific 
incidence rates were tabulated in age a by calendar year period p arrays with diagonal 
elements of the matrix corresponding to the birth cohorts c (c = p + a -1), where the 
oldest cohort is observed for the oldest age interval during the earliest calendar period 




calendar period.  Seven 5-year age groups, ranging from 65 – 69 to 95 – 99, and six 5-
year time periods, from 1973 – 1977 to 1998 – 2002 were used in the analysis.  There is 
some ambiguity in the measurement of cohorts because data are tabulated into 5-year age 
and period groupings.  For example, an individual age 69 in 1973 would have a birth year 
of 1904 while an individual age 65 in 1978 would have a birth year of 1913.  This yielded 
12 successive ten year birth cohorts with midpoints ranging from 1878 – 1933, which 
were used for the age, period, and cohort (APC) analyses.   
Traditional APC analyses suffer from an “identification problem” resulting from 
the linear dependency between age, period and cohort (c=a +p), precluding a unique 
solution.  This problem can be solved by imposing constraints to the model to allow for 
an identifiable solution (Arbeev et al., 2005a; Arbeev, Ukraintseva, Arbeeva, & Yashin, 
2005b; Carstensen, 2007; Yang, Fu, & Land, 2004).   However, selection of the 
constraint requires some a priori knowledge of the disease under investigation and 
models are sensitive to the constraint selected.  Other authors have suggested using a 
proxy characteristic for cohort (O'Brien, 1989, 2000; O'Brien, Stockard, & Isaacson, 
1999). However, cohort characteristics may not entirely explain cohort effects and the 
residuals may still be confounded in the model estimates with age and period effects.  
The Intrinsic Estimator (IE) proposed by Yang et al. (Yang et al., 2004; Yang, 
Schulhofer‐Wohl, Fu, & Land, 2008) can also be viewed as a constrained approach; 
however, it does not require a priori assumptions about the constraints.  Other studies 
have shown that the IE produces substantively meaningful and empirically valid results 
(Yang et al., 2008), and the effects can be interpreted like conventional regression 
coefficients (D. J. Harding, 2009).  The limitations to this approach include the lack of a 




(D. J. Harding, 2009; H. L. Smith, 2004).  After initial estimations of a series of Poisson 
log-linear models, we selected the IE to estimate the APC effects of cancer incidence 
based on evidence of distinct age, period, and cohort effects and model fit.   
 Descriptive plots were produced by age group and sex for all-site, breast, colon, 
and prostate cancers to assess the age, period, and cohort cancer incidence trends.  Trends 
in lung cancer incidence rates were not assessed as part of this analysis because the 
incidence rates in Utah are very low (Jemal et al., 2008) and the case counts above age 85 
were sparse.  A similar approach to that used by Yang et al. (Yang et al., 2004; Yang et 
al., 2008) was used to identify an appropriate model to analyze the temporal trends in all-
site and site-specific cancer incidence rates.  A series of Poisson log-linear models were 
estimated for each site and sex:  
                        ln(mijk) = ln(cijk/nijk) = μ + αi + βj + γk  (eq. 2.1) 
 
where rateijk indexes the expected cancer incidence rate in cell (i, j, k); cijk indexes the 
observed number of cancer incidence cases; nijk indexes the number of person years; µ 
indexes the intercept of age adjusted mean rate; αi indexes the ith row age effect for i = 1, 
. . . , a age groups; βj represents the jth column period effect for j =1, . . ., p periods; and 
γk represents the kth diagonal cohort effect for k =1, . . ., (a + p -1) cohorts. 
One-way models (a, p, or c), two factor models (ap, pc, ca) and IE models were 
compared.  Both descriptive analyses and model fit, based on the Akaike Information 
Criterion (AIC), were used to select the final models.  Full analyses are available upon 
request.  The log-linear regression coefficients, standard errors, and model fit were 
computed using Stata 11. 2. Estimates of the full APC models using the IE approach and 




were sensitive to method of denominator construction, the final models were replicated 
using denominators constructed using the extinct cohort method.   
 
Results 
 To assess the variation in age-specific incidence by period a series of age-period 
plots were created.  Figure 2.1 shows the sex-specific age and period all-site cancer 
incidence rate plots.  Each panel displays the age-specific incidence trends by calendar 
period, ranging from 1973 - 1978 to 1998 - 2002.  The solid lines present the full 85+ 
age-specific rates and the dashed lines display the trend when cancer rates are top-coded 
at age 85.  These plots show that when rates are aggregated for the 85 plus age group, 
specious conclusions about the age at which incidence rates peak may be drawn.  These 
plots indicate that for the vast majority of the periods, the age group with the highest 
incidence rates can be found in the 85 to 89 age groups.  The peak is then followed by a 
leveling off or decline for the 90 to 94 and 95 to 99 age groups.  These plots also show 
that the trends are not stable over time.   If the only factor influencing cancer incidence 
trends were age, one would expect the age-specific curves for all periods to follow 
similar trajectories.  However, the plots show variation in the intercept (depicted for age 
65 - 69), slope, and shape of the curve.  There has been a steady increase in the level of 
cancer incidence over time, with the most recent periods having the highest rates for a 
majority of the age groups.   
Age-cohort plots were created to assess the variation in the age trends by birth 
cohort and sex.  Figure 2.2 displays the variation in shape, slope, and peak in all-site 
cancer incidence age trends by cohort for both males and females.  We are unable to 




window only, from 1973 - 2002.  Age trends for the 1903 and 1908 cohorts have the 
longest follow-up, with incidence calculated for ages 70 to 99 and 65 to 94, respectively.  
There is less variation in the trend in age specific incidence rates between cohorts for 
females as compared to males.  The plots suggest that for men the peak in incidence is 
moving to younger ages for more recent birth cohorts; however, these peaks coincide 
with the expected rise in incidence that resulted from the PSA testing for prostate cancer.  
There is a general increase in cancer incidence rates at younger ages for more recent 
cohorts for both males and females.  For both sexes, the largest differences in cancer 
incidence occur at ages 90 – 99.  The imprecision at advanced ages is partially a function 
of decreased sample sizes.  The age-period and age-cohort plots indicate period and 
cohort factors may confound observed trends in age specific cancer incidence.   
 A series of Poisson log-linear and IE models were used to further investigate age, 
period, and cohort effects.  The goodness-of-fit statistics for the log linear models are 
displayed in Table S1 in the online supplement.   The IE model provided the best fit for 
both male and female all-site cancer, female breast cancer, and prostate cancer incidence.  
The fit statistics suggest weak cohort effects for women, with the IE model only 
providing a slightly better fit than the age-period models for both all-site and breast 
cancer incidence.  The age-period model provided the best fit for both male and female 
colon cancer incidence models.   
Figure 2.3 shows the IE results for all-site cancer incidence by sex.  The figure 
shows an increase across ages in cancer incidence up to age 85.  All-site cancer incidence 
rates are the highest for the 85 to 89 age group net period and cohort effects for both 
males and females.  Female all-site incidence rates for ages 90 and above level off and 




all-site incidence rate for  males after age 85; however, it is noteworthy that the estimated 
coefficient for rates at age 90 (p=0.06) is still higher than the estimated rates for both the 
60 to 64 and 65 to 69 age groups.   
The period specific trends show that there has been a gradual increase in cancer 
incidence over time.  While this gradual increase in cancer incidence with time may be 
indicative of changes in screening behaviors or environmental exposures, it may also be 
an artifact of changes in cancer surveillance methods, with more complete identification 
of cases recorded over time.  The period effects for males are as expected based on the 
descriptive analyses and the known increase in cancer incidence between 1988 and 1992, 
which is attributable to shifts in prostate screening practices.  The rates drop to pre-1988 
levels in the next period and continue their decline into the 1998 – 2002 period.   
Figure 2.3 also shows that there are moderate cohort effects for females.  All-site 
cancer incidence was significantly higher for the 1888 and 1893 birth cohorts and lower 
for the 1928 birth cohort.  The cohort effects for males resemble a trough, with slightly 
elevated risk (albeit insignificant) for early cohorts, followed by a decline and leveling 
off for the 1903 to 1917 birth cohorts, and ending with an increase that almost reaches the 
height of the 1883 birth cohort.   
 Figure 2.4 displays the IE estimates for breast and prostate cancer.  The age 
effects for the site specific cancers are somewhat different than the all-sites trends.  For 
females, the highest level of breast cancer incidence and the only estimate significantly 
different from zero, is found between the ages of 75 to 79 (p=0.03). The period effects 
are similar to those observed in the all-site rates as there is a gradual increase in female 
breast cancer incidence over time.  Cohort effects play a small role in determining female 




birth cohort is somewhat consistent with previous studies that show a decline in breast 
cancer incidence for the 1924 to 1938 birth cohorts (Lacey, Devesa, & Brinton, 2002).  
The age effect for males steadily increases up to age 75 where it reaches a plateau 
followed by a decline at age 90.    Male prostate cancer incidence steadily increases up to 
1988 and then sharply declines over time, again for reasons of PSA testing.  Male cohorts 
between 1898 and 1918 have slightly lower rates of prostate cancer incidence. A steady 
rise in prostate cancer rates is seen in subsequent cohorts.   
 Figure 2.5 shows the estimated coefficients for the log-linear AP models of colon 
cancer incidence.  Fit statistics showed that the two-factor model provided the best fit for 
colon cancer incidence, meaning that cohort effects can be constrained to zero.  Fig. 2.5 
indicates that there is a steady increase in colon cancer incidence with age up to age 85, 
followed by a slight decline (albeit still significantly higher than the referent category of 
65 – 69) at the advanced ages.  The period trends show a slight elevation in colon cancer 
incidence between 1983 and 1987 for females and between 1983 and 1992 for males as 
compared to the sex specific incidence rates in 1973 – 1977.  
 To test the sensitivity of our findings, the final models were estimated using 
denominators created using the extinct cohort method.  The results did not substantively 




This study found evidence supporting hypotheses of an increase in all-site cancer 
incidence up to ages 85-89 net period and cohort effects, followed by a modest decline up 
to age 99.  Although incidence appears to drop after age 90, the rates up to age 99 are still 




and highlights the importance of disaggregating cancer incidence rates for the oldest old 
(C. Harding et al., 2008; D. W. E. Smith, 1996).  We found evidence of period and cohort 
effects influencing cancer trends, which highlights the importance of considering the 
social factors that influence biology when studying cancer trends in this population.  The 
benefits of disaggregated estimates for the oldest old far outweigh the potential 
challenges related to age misreporting.  As more people reach these advance ages, it will 
become increasingly important to understand the biological and social mechanisms 
affecting cancer trends in the oldest old.  These results answer Boscoe’s call for greater 
specificity in age-specific data for the oldest old (Boscoe, 2008).    
We conclude that the age, period, and cohort effects of site specific cancer 
incidence varied by site and sex.  Physiological mechanisms have been the primary 
mechanisms used to explain the decline in incidence by other authors.  Harding et al. 
propose a simple senescence theory, claiming that increasing senescence reduces the 
ability of cells to divide and limits cancer incidence in the oldest old population (C. 
Harding et al., 2008; C. Harding, Pompei, & Wilson, 2012).  Our results suggest that age 
is not the only factor contributing to the decline in cancer incidence in the oldest old age 
group.  We are not arguing against a biological model of cancer decline, but we do 
advocate a more inclusive theory that considers socio-environmental factors and 
mortality selection, which may influence the age-specific trends.   
For women, the gradual increase in all-site and breast cancer incidence over time 
may be partially due to increased detection by mammographic screening (Edwards et al., 
2002) and improvements in data collection and classification.  These trends in breast 
cancer incidence are also consistent with previously reported trends in breast cancer (C. 




dramatic increase in cancer incidence up to the 1988 – 1992 period is consistent with 
other studies of period trends in prostate cancer incidence (Edwards et al., 2002) and the 
introduction of the PSA screening test.  The clear period trends observed for both men 
and women bring attention to the importance of understanding how period factors 
influence cancer incidence. 
In our study, cohort effects played a larger role for males than females and did not 
affect colon cancer incidence rates.  Our results show variations in cohort trends of 
cancer incidence over time that coincide with changes in environmental exposure to 
tobacco products.  Birth cohort did not explain variation in incidence trends for all sites in 
this study.  The absence of a cohort trend in colon cancer incidence is inconsistent with 
other studies of colon cancer trends (Chu, Tarone, Chow, Hankey, & Ries, 1994); 
however, cancer mortality trends may reflect improvements in detection and treatment 
that prevent colon cancer mortality but do not necessarily modify the risk of colon cancer 
incidence (which was not reported in this study).   Failing to account for heterogeneity 
between cohorts may lead to erroneous conclusions about deceleration in trends where 
none exists (Gavrilov & Gavrilova, 2011).  We have shown that there is a difference in 
cancer susceptibility between cohorts, but controlling for these differences does not alter 
the conclusion that cancer incidence rates do not exponentially increase with age.  
Heterogeneity within a birth cohort may also be an important mechanism driving 
the deceleration and decline in cancer incidence in the oldest old.  Declines in the force of 
mortality at all ages may lead to increased population heterogeneity at old ages, thus 
possibly cohorts of individuals with more susceptibility to cancer (Hawkes et al., 2012).  
However, it is also possible that there is less within-cohort heterogeneity in more recent 




population frailty in birth cohorts in more contemporary cohorts, suggesting that the 
population is becoming more homogeneously robust (Lynch & Brown, 2001).  If this is 
true, then it is possible that cancer incidence rates will decline in the future.  The gradual 
increase in cancer incidence for males during more recent birth cohorts, reported here, 
suggests changing cohort susceptibility to cancer, a position inconsistent with the 
argument that populations shift to become more homogenously robust.  While it is 
difficult to separate the environmental factors from the changes in population 
heterogeneity, this finding emphasizes the importance of both improved surveillance in 
cancer trends for the oldest old and consideration of cohort effects when studying oldest 
old cancer trends.     
Variation in health and cancer screening behaviors with age may also explain the 
decline in incidence and sex differences in period and cohort effects.  Sex differences in 
cohort experiences may reflect sex differences in the timing, prevalence, and frequency 
of smoking; sex differences in environmental exposures to carcinogens in the work place; 
or sex differences in other risky behaviors that are patterned by generational experiences.  
For example, Preston and Wang (2006) have demonstrated the close relationship between 
a cohort’s mortality trajectory and its history of cigarette smoking as well as sex 
differences in smoking prevalence within the cohort.  It is unlikely that between-cohort 
variability or period specific shifts in health behaviors are strong determinants of the age-
specific trend in cancer incidence because incidence rates decline above age 90 when 
controlling for cohort and period trends.   
 Screening bias is another individual level component that may reduce cancer 
incidence for the oldest old.  For example, there were strong period effects associated 




the oldest age categories at the time PSA testing was introduced have decreased cancer 
incidence rates relative to those cohorts that would have been under the age of 85.  This 
finding emphasizes the importance of both improved surveillance in cancer trends for the 
oldest as well as further investigation into the causes of cohort differences in cancer 
incidence.   Kaplan and Satlzstein note parallel downward sloping trends between breast 
cancer screening and prevalence in the aged population (Kaplan & Saltzstein, 2005).   
However, other studies not subject to screening bias show a similar trend (Stanta, 1997).  
This study also suggests that screening bias may not be the reason for decreases in cancer 
incidence with age.  SEER data collection processes include checking death certificate 
information.  Any cancer occurrence contributing to the cause of death of an individual is 
reported to the SEER registries.  Only cancers that are not an underlying factor in the 
death would be missed by the system, suggesting that detection bias is not a likely cause 
in the observed decrease in cancer at advanced ages.  
Our results differ slightly from previously reported trends in cancer incidence.  
The estimated peak in incidence in the 85 – 89 age category for males and females is 
higher than the Harding et al. (2008) estimates of 80.  However, our results are consistent 
with the peak observed by Saltzstein et al. (1998).  There are three possible explanations 
for the variation in the estimated peaks in age-specific incidence rates.  First, previous 
studies of age-specific cancer incidence in the oldest old age group have not considered 
the role of period and cohort effects.  Ignoring exogenous factors that may contribute to 
cancer incidence oversimplifies the problem and leads to the age-specific incidence rates 
that are confounded by period and cohort differences in cancer incidence.  APC analyses 
of cancer incidence may provide less biased estimates of the true relationship between 




Second, the differences may be caused by error in the estimated denominators.  
Preston et al. (1999) found that the difference between the correct population distribution 
and one estimated with age overstatement increased with time (Preston et al., 1999).  Any 
difference between the estimated peak cancer incidence and the true peak cancer 
incidence should be negative.  If age-misstatement led U.S. to overestimate the size of the 
oldest old population, then our estimate of a peak in incidence between the ages of 85 and 
89 is conservative.  Furthermore, because other studies have also used decennial census 
data to construct their denominators (C. Harding et al., 2008; C. Harding et al., 2012), we 
argue that this is not the reason for the observed differences in peak age-specific 
incidence rates.   
Third, while not directly assessed, our findings are suggestive of geographic 
variation in cancer incidence trends given the difference in the estimated peak of cancer 
incidence between our study and other U.S. studies of overlapping time periods (Harding 
et al., 2008; Harding et al., 2012; Saltzstein et al., 1998).   Regional differences in cancer 
incidence trends may be attributable to differences in sociodemographic characteristics, 
health beliefs, access to resources, reproductive characteristics, and exposure to 
environmental carcinogens.  Utah consistently has one of the lowest cancer incidence and 
mortality rates in the U.S. for both males and females and the lowest rates of lung cancer 
incidence and mortality (Jemal et al., 2008). However, Utah does not have low incidence 
rates for all cancer sites. Age-adjusted prostate cancer incidence rates are higher in Utah 
than the national averages (Stroup et al., 2008).   More research should be done to 
quantify geographic differences as it will provide valuable information about the social 




There are several structural limitations to studying cancer trends in the oldest old 
age groups.  Use of clinical and death certificate diagnoses may lead to an underreporting 
of trends in the oldest old (Kaplan & Saltzstein, 2005; Stanta, 1997).  Trends calculated 
using cancer registry and census data are subject to error because the reliability of age 
estimates for individuals over the age of 85 may be  questionable (Edwards et al., 2002; 
Vincent et al., 2010).  However, we used several different methods to create measures of 
population size and found no substantive differences in the age, period, and cohort trends 
in all-site cancer incidence.     
 There is not widespread consensus in the cause of the decline in cancer rates at 
advanced ages because it has been largely understudied.  This study contributes to the 
current literature by providing estimates of cancer incidence for the 85+ population 
within the broader context of period and cohort effects.  This study supports the 
individual risk hypothesis and mortality selection arguments that predict a deceleration in 
incidence at advanced ages.  Our findings do not support the position that deceleration is 
an artifact of variability in morbidity profiles between cohorts, nor do they support 
arguments that cancer incidence trends are strictly a function of biological mechanisms. 
Studies utilizing an APC approach to the analysis of cancer trends may provide less 
biased estimates of the relationship between cancer and aging and improve knowledge 
about the role of biological and social influences that modify trends. The existence of 
cohort and period effects also justifies the use of direct measures of the exogenous factors 
contributing to cancer incidence.  Future studies should evaluate the proportion of 
variation in cancer incidence explained by direct measures of period influences and 
cohort characteristics.  Future studies should also investigate morbidity trends in other 




deceleration.  We also show that there is variation in cancer incidence trends in the oldest 
old population and reiterate the importance of treating this population as heterogeneous.  
In order to gain a more comprehensive understanding of morbidity and mortality patterns 
for this rapidly growing segment of the population, cancer incidence and U.S. Census 
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Figure 2.1.  All-site cancer incidence rates by age and period.  Panels A and B show Utah 
females and males, respectively.  Solid lines show trends up to age 99 and dashed lines 






Figure 2.2.  All-site cancer incidence by birth cohort.  Panels A and B show Utah females 
and males, respectively.  The scale of the y-axis is smaller than the scale for the male 
graphs to allow for the visibility of the variation.  Female incidence rates are lower 







Figure 2.3.  APC IE estimated trends of all-site cancer incidence rates for ages 65 to 99 in 
the state of Utah.  Dotted lines represent 95% confidence intervals.  Panel A: Age effects 
net period and cohort.  Panel B: Period effects net age and cohort.  Panel C: Cohort 






Figure 2.4.  APC IE estimates of female breast and male prostate cancer incidence rates 
for ages 65 to 99 in the state of Utah.  Dotted lines represent 95% confidence intervals.  
Panel A: Age effects net period and cohort.  Panel B: Period effects net age and cohort.  










Figure 2.5.  Poisson log-linear estimates of age and period effects on colon cancer 
incidence.  Dotted lines represent 95% confidence intervals.  Panel A: Age  
















The reproductive lives of men and women may provide significant insight into 
later-life health and mortality.  Sociological, biological, and evolutionary theories predict 
a relationship between reproductive history and later-life health and mortality, however, 
current research is lacking consensus on the direction of the relationship.  In this study, 
the relationship between reproductive history and later-life health is examined using data 
based on linkages between the Utah Population Database, a rich source of longitudinal 
data, and 18 years of Medicare Claims data. Later-life health is measured using the 
Charlson Comorbidity Index, a construct that summarizes nearly all serious illnesses 
afflicting older individuals. Single year comorbidity scores are constructed by year from 
1992 to 2009.  We used group based trajectory modeling that accounts for nonrandom 
attrition due to death to identify the number and types of morbidity trajectories by sex 
and age group for 52,924 individuals aged 65-84 in 1992.  For both males and females, 
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trajectory groups ranged from a robust group with little to no comorbid conditions during 
the period of observation to a frail group with a consistently high comorbidity.  Parity, 
age at first birth, age at last birth, birth weight of offspring, having a child die as an 
infant, and having a preterm birth predicted trajectory group membership for women but 
had little association with trajectory group membership for men. 
 
Introduction 
Understanding how individuals experience disease after age 65 is important to 
understanding the mechanisms of aging and longevity.  Equally important is what 
predicts the observed patterns.  The etiological model of chronic disease has shifted its 
focus from adult risk factors to considering factors throughout the life course (Kuh & 
Ben-Shlomo, 2004).  Central to the life course approach is the idea that there are certain 
periods of plasticity, where individuals may experience physiological or social change 
that alter their future health trajectories.  The reproductive period is a sensitive period for 
both men and women, in which the timing of births, number of births, and birth outcomes 
might have adverse or protective effects on later-life health.  It also presents a critical 
period for women as physiological changes related to pregnancy may have lifelong 
effects on the structure or function systems in the body (Kuh & Ben-Shlomo, 2004; Kuh 
& Hardy, 2002).  Therefore, the reproductive lives of men and women may provide 
significant insight into later-life health and mortality, but current research is lacking 
consensus on the direction of the relationship.    
This study will examine the role of parity, age at first birth, age at last birth, 
interbirth intervals, infant death, multiple births (twins), birth weight of offspring, and 




utilizes Centers for Medicare Services (CMS) data spanning from 1992 – 2009 linked to 
the Utah Population Database, which is a rich source of longitudinal data.  The goals of 
this analysis are threefold: 1- identify distinct trajectories of comorbidity from 1992 - 
2009 for individuals aged 66 – 84 in 1992 by sex and birth cohort; 2- estimate the 
association between measures of fertility and later-life comorbidity trajectories while 
controlling for early-life circumstances using information from a longitudinal, familial 
health database; 3- determine if the observed effects are part of a trajectory set in motion 
earlier during infancy and childhood (i.e., does fertility mediate known relationships 
between early-life circumstances and later-life comorbidity trajectories (K. R. Smith, 
Hanson, & Zimmer, 2012)).   
 
Background 
There is a substantial amount of variation in the morbidity profile of older adults, 
suggesting that morbidity is not an inevitable consequence of aging (Rowe & Kahn, 
1987; Rowe & Kahn, 1997).  Understanding the sources of variation in patterns of aging 
is important for creating accurate population predictions, identifying at risk populations 
that may benefit from public health interventions, and characterizing the process of aging 
in a diverse population.  Sources of heterogeneity in patterns of aging cannot be 
understood by restricting analyses to a single life stage, nor can its intricacies be 
understood without simultaneously considering biological and social mechanisms.  The 
pathology of chronic disease is multifaceted, determined by genetic profiles, biological 
and physiological development, and the social environment, with the strength and relative 




The majority of studies assessing the relationship between reproductive history 
and health have focused on mortality with mixed results.  Numerous studies have also 
demonstrated the relationship between reproductive history and later-life health as 
measured by activities of daily living (ADL), depressive symptoms, type 2 diabetes, 
cardiovascular disease, self-rated health, self-reported limiting chronic illness, cancer, 
and mental health (D. Smith, Sterne, Tynelius, & Rasmussen, 2004; Grundy & 
Tomassini, 2005; Henretta, 2008; Kravdal, 1995; Lawlor et al., 2003; Myklestad et al., 
2012; Spence, 2008; Yi & Vaupel, 2004). Yet none has looked at the relationship 
between reproductive history and comorbidity.  These studies also often fail to account 
for early-life conditions that may influence reproductive history and later-life health.   
Comorbidity is one of the major components of health aging, and its presence 
increases with age (L. P. Fried, Ferrucci, Darer, Williamson, & Anderson, 2004; 
Guralnik, 1996).  However, there is variation in the rate at which a transition into a 
comorbid state occurs and the trajectory of disease once it has occurred.  We assume that 
heterogeneity within a population follows a specific distribution, with robust individuals 
on one tail and frail individuals on the other.  Therefore, unlike the geriatric definition of 
frailty which refers to a variable state of physiological decline, we intend to invoke the 
demographic meaning of the term.  For example, individuals exhibiting a robust 
phenotype may delay or evade chronic disease completely, while individuals exhibiting 
the frail phenotype experience multiple morbid conditions (Andersen, Sebastiani, 
Dworkis, Feldman, & Perls, 2012; Evert, Lawler, Bogan, & Perls, 2003; Ken R.  Smith et 
al., 2012).  Identifying sources of this phenotypic variation is necessary for targeting 
periods of the life course that affect later-life health and to more fully understand the 




model explaining the direct and indirect effects of childhood circumstances on later-life 
health.  A similar model can be used to classify the theories that predict a relationship 
between fertility history and later-life health.  Evolutionary, biological, and social 
theories predict that parity, age at first birth, age at last birth, interbirth intervals, 
twinning, birth weight of offspring, and giving birth prematurely may all be associated 
with later-life morbidity and mortality.  
  
Evolutionary and Genetic Theories Linking  
Reproductive Health to Aging 
Evolutionary theories predict a close relationship between fertility and mortality.  
Optimization hypotheses suppose that the forces of evolution select for traits that 
maximize the reproductive success of an organism.  Two such hypotheses, disposable 
soma and antagonistic pleiotrophy, predict a positive association between parity and 
comorbidity at advanced ages (Kirkwood & Rose, 1991).  The disposable soma theory 
argues that the two physiological costly functions of reproduction and somatic 
maintenance are in direct competition for a limited amount of resources.  This “trade-off” 
yields optimal reproductive success at the cost of longevity for females (Kirkwood & 
Rose, 1991).  Similarly, antagonistic pleiotrophy suggests that genetic mutations that 
increase postreproductive mortality may escape the force of natural selection because 
they increase fitness early on (Kirkwood & Rose, 1991; G. C. Williams, 1957).  A recent 
study of fertility in carriers of the breast cancer genes BRCA1 and BRCA2 suggests that, 
although these mutations significantly increase the risk of mortality, they may increase 




Smith, Hanson, Mineau, & Buys, 2012).  These theories predict that for females, young 
age at first birth and high parity are associated with increased comorbidity later in life. 
High parity, late age at last birth, multiple births, and short birth intervals may 
also be associated with decreased comorbidity later in life.  For example, it has been 
suggested that genetic variants influence both late female fertility and slowed rates of 
somatic aging (K. R. Smith et al., 2009). Fertility success may also be an indication of 
health status and robustness.  Women with higher fertility, shorter birth intervals, twins, 
and later ages at last birth may have increased longevity because their fertility success is 
a marker of a robust phenotype (Hawkes, 2010; Robson & Smith, 2011, 2012).  While 
evolutionary theories are an important factor in the relationship between fertility and 
later-life morbidity and mortality, it is necessary to consider the direct biological and 
indirect social effects of fertility history. 
 
Direct Biological Effects of Reproductive Health and  
Biological Indicators of Later-Life Health 
In the life course literature, physiological scarring has been used to define an 
event that permanently alters the physiological functioning of an organism.  For women, 
pregnancy may trigger physiological changes that may favorably or adversely affect 
later-life health.  Increased parity and early age at first birth have been shown to lower 
the risk of postmenopausal reproductive cancer and it has been posited that biological 
factors are responsible for this link.  Pregnancy is one of several factors that determine 
life time exposure to endogenous hormones.  Several hypotheses relate the level of 
endogenous hormones throughout the life course, such as androgen, insulin, 




Kobayashi et al., 2012; Lukanova & Kaaks, 2005).  There is an inverse association 
between parity and cancer incidence in tissues sensitive to hormone levels, such as breast, 
endometrial and ovarian (Kelsey et al., 1993; Kobayashi et al., 2012; Kvale, Heuch, & 
Nilssen, 1994; Permuth-Wey & Sellers, 2009).  Age at first birth has also a known risk 
factor for breast cancer, with younger age at first birth being a protective factor 
(MacMahon, Cole, & Brown, 1973).   
Reproductive history may also lead to physiological changes that adversely affect 
a woman’s health.  Pregnancy related biological responses may lead to increased risk for 
coronary heart disease and obesity later in life (Bastian, West, Corcoran, & Munger, 
2005; Lawlor et al., 2003).  A study of men and women aged 60 to 79 in Britain found a 
positive association between number of children and adverse lipid profiles and diabetes 
for women but not men, suggesting possible biological mechanisms (Lawlor et al., 2003). 
However, life style factors were also found to play a role in the association.  Birth 
spacing and having multiple births (twins) may also leave a physiological imprint on the 
mother.  The maternal depletion hypothesis argues that the physiological demands of 
pregnancy diminish physical resources and short birth intervals do not give the mother 
ample time to recover from the stresses of the previous pregnancy (Jelliffe & Jelliffe, 
1978; Kirkwood & Rose, 1991).  These theories predict a positive relationship between 
parity, short birth intervals, and multiple births and later-life comorbidity. 
Characteristics of a mother’s offspring at time of birth can be used to gauge the 
woman’s health during her reproductive period and may predict her health status as she 
ages.  Birth weight of her child and giving birth prematurely are examples of markers of 
the health and vitality of the mother (G. D. Smith, Whitley, Gissler, & Hemminki, 2000).  




indication of pregnancy complications that affect the mother’s health, such as gestational 
diabetes  (Casey, Lucas, McIntire, & Leveno, 1997), which is a known risk factor for 
diabetes and cardiovascular disease later in life (Bellamy, Casas, Hingorani, & Williams, 
2009; Carr et al., 2006).  Studies have shown that there is a positive association between 
birth weight of offspring and the mother’s longevity (G. D. Smith et al., 1997; G. D. 
Smith et al., 2000).  However, the studies do not test whether there is a threshold to this 
effect.  There are several reasons for these associations.  First, it may be an indicator of 
the social and physical environment of the mother, with conditions affecting the 
development and health of both mother and fetus.  Second, it may be indicative of genetic 
variants carried by the mother or father that predispose them for cardiovascular disease 
later in life (Myklestad et al., 2012).  These studies suggest that high birth weight, low 
birth weight, and preterm babies are positively associated with adverse health outcomes 
later in life.   
 
Social Mechanisms Indirectly Linking Reproductive  
History to Later-Life Health 
 Social theories predict both positive and negative relationships between parity and 
later-life morbidity.  The social benefits of adult children may negate any adverse 
physiological effects of having children by providing social support, social engagement, 
and receipt of instrumental help.  Strong social support may foster feelings of meaning, 
reduce feelings of stress, and minimize risky behavior. Individuals with more social 
support and intimate ties have better health and lower levels of mortality (Berkman & 
Syme, 1979; House, Landis, & Umberson, 1988).   Children may provide a support 




contact with at least one child (Uhlenberg & Cooney, 1990) and receipt of help from 
children (Grundy & Read, 2012).  Later ages at first birth may allow for accumulation of 
wealth and resources and prevent adverse health outcomes later in life.   
Psychological, social, and economic impacts of children may also lead to a 
negative relationship between parity and later-life morbidity.  Increasing parity is 
associated with obesity and coronary heart disease for both men and women, suggesting 
that lifestyle factors associated with high parity may lead to increased risk of morbidity 
later in life (Lawlor et al., 2003). Increased parity may not translate to increased social 
support.  Smith (2002) suggests that high parity children may have fewer resources to 
devote to their parents and, due to the intergenerational transmission of fertility, high 
parity may lead to decreased social support from children later in life. These results 
suggest that the effect of fertility may be positive or negative for males and females.   
Early parenthood may lead to decreased opportunities for education and 
employment (Ross & Huber, 1985; Waldron, Weiss, & Hughes, 1998), which has been 
shown to lead to adverse health consequences later in life (Mirowsky, 2005; Phelan, 
Link, & Tehranifar, 2010).  Mirowsky (2005) suggests that the optimal period for 
childbirth in relation to health is the mid-thirties, but this finding may be unique to the 
historical and social environment.  The current literature presents conflicting findings 
related to the benefits of age at last birth after age 39, with some studies suggesting that 
later ages at last birth are protective (K. Smith, G. Mineau, G. Garibotti, & R. Kerber, 







Considering Events Throughout the Life Course that  
Affect Fertility and Morbidity 
Failure to look at the relationship between fertility and morbidity using a life 
course perspective and controlling for early-life circumstances can lead to an 
overstatement of their association.  Early-life factors may affect the reproductive health 
and behaviors of men and women (Doblhammer & Oeppen, 2003; Rich-Edwards, 2002).   
Therefore, part of the observed association between fertility and later-life morbidity may 
be merely a reflection  of genetic makeup or physiological changes during childhood.  
For example, adverse childhood and adolescent circumstances are also related to early 
motherhood (Geronimus & Korenman, 1992) and later-life health (Galobardes, Lynch, & 
Smith, 2008; Preston et al., 1998; K. R. Smith, G. P. Mineau, G. Garibotti, & R. Kerber, 
2009).  These are important confounders that must be controlled for when studying the 
effects of fertility on later-life morbidity.  For this reason, we will include measures of 
early-life circumstances that may affect fertility and later-life health outcomes. 
 
Hypotheses 
The research question addressed in this paper is whether measures of fertility and 
reproductive health are associated with morbidity profiles later in life.  We will examine 
the role of parity, young age at first birth, age at last birth, interbirth intervals, infant 
death, multiple births (twins), birth weight of offspring, and preterm births for both men 
and women.  We are able to control for a range of early-life circumstances, including a 
familial predisposition to longevity, childhood socioeconomic status, and death of a 
parent during childhood.  The specific hypothesis generated by suggested evolutionary, 




 H1: The optimization of life history traits leads to a “trade-off” between 
fertility and somatic maintenance.  According to this hypothesis, young 
age at first birth, increased parity and shorter birth intervals should be 
positively associated with comorbidity after age 65 for females, and age at 
last birth should be negatively associated with comorbidity after age 65. 
 H2: Childbirth leads to physiological changes that affect later-life health.  
According to this hypothesis, increased parity, shorter birth intervals, later 
age at last birth, and unhealthy (high/low) birth weight of offspring should 
be adversely associated with later-life comorbidity after age 65 for females 
but not males.  Early age at first birth and parity may also have protective 
effects for females but not males. 
 H3: Reproductive history is a marker of a robust phenotype.  According to 
this hypothesis, increased parity, shorter birth intervals, later age at last 
birth, and twinning should be negatively associated with comorbidity after 
age 65 for both sexes and is possibly stronger for females.   
 H4: Social mechanisms are responsible for the observed association 
between reproductive history and comorbidity after 65.  According to this 
theory, the observed effects of fertility history should be similar for males 
and females, but there are competing hypotheses about the direction of the 
effect.   
 H4a: Increased parity is negatively associated with comorbidity 
after age 65 because children provide material, instrumental, and 




 H4b: Increased parity is positively associated with comorbidity 
after age 65 because the psychological, social, and economic 
effects of having children outweigh the social benefit.  Children 
may also be unable to provide support because they are caring for 
their own large families. 
 H4c: Early age at first birth is positively associated with 
comorbidity after age 65 because it leads to constrained economic 
and educational opportunities.  Late age at first birth is negatively 
associated with comorbidity after age 65 because it leads to 




The majority of life-span epidemiological studies examine health influences of 
early and adult life conditions with relatively modest sample sizes. This study utilizes 
data drawn from the Utah Population Database (UPDB). The UPDB is one of the world’s 
richest sources of linked population-based information for demographic, genetic, and 
epidemiological studies. UPDB has supported biodemographic studies as well numerous 
important epidemiological and genetic studies in large part because of its size, pedigree 
complexity, and linkages to numerous data sources. The full UPDB now contains data on 
nearly 7 million individuals due to longstanding and on-going efforts to add new sources 
of data and update records as they become available (e.g., including all statewide death 
certificate records (1904-present) and all Medicare claims (1992-2009). We have 




individuals for whom early and midlife conditions are measured and who are linked to 
their adult medical records generated decades later. These complex data links provide 
unparalleled data quality and depth that focus on families (nuclear, multigenerational, full 
pedigrees) and health outcomes that span entire life spans of individuals and their 
relatives. 
Given the large sample sizes and the quickly changing morbidity risks by age and 
sex, we will conduct all analysis by sex and 10 year age categories (66-74 and 75-84).  
The first age category begins at age 66 to eliminate the problems of prorating the partial 
year coverage of individuals who become age eligible part way into a year when they 
turn age 65.  Ages are considered in 1992, the first year in which we have Medicare data.  
Separating samples by age effectively holds the cohort constant and allows us to analyze 
the trends by birth cohort for an 18 year period.  Individuals aged 66 – 74  and 75 – 84 in 
1992 are considered members of the young-old cohort (born between 1918 and 1926) and 
old-old cohort (born between 1908 and 1917), respectively.  
We selected once married parous individuals.  Once married individuals were 
selected to limit complications related to fertility spanning more than one marriage 
partner.  We excluded individuals with a spouse deceased before the individual reached 
age 50 because they would not have completed childbearing (Gagnon et al., 2009).  The 
CMS data requires an individual to survive to the age of 66, therefore, by definition, the 
remaining individuals would have completed their childbearing.  Selecting parous 
individuals helps identify the multivariate effects of both the intensity and timing of 
fertility on comorbidity trajectories.  It is also a necessary restriction because the UPDB 
is derived from descendent genealogies in which identification of nulliparous women is 




not intended to account for the impact of childlessness (Gagnon et al., 2009; K. R. Smith 
et al., 2002).  Individuals were also required to have sufficient information about parents 
in the database, which allowed for the inclusion of early-life circumstances in the model.  
Centers for Medicare Services (CMS) provides files that allow us to assess 
whether individuals are sufficiently represented in the Medicare claims data so that they 
can contribute to the construction of the morbidity trajectories. Our goal is to avoid 
characterizing someone as being disease-free when in fact their health events are simply 
not well represented in the Medicare data. CMS provides a monthly HMO indicator 
variable that describes when a beneficiary was enrolled in a managed care plan.  As 
expected, few claims exist in the file for individuals during the time they are enrolled in a 
managed care plan. For the purposes of this analysis, we exclude persons who have at 
least 1 month of enrollment in a managed care plan. We also required all individuals to 
have at least 1 full year of data and, therefore, all individuals deceased in 1992 were 
excluded from the sample.   
Subjects who met our data requirements (e.g., once married parous individuals for 
whom we have family data (parental death dates and full fertility history)) and had 
sufficient Medicare claims data are shown in Table 3.2. Individuals were then followed 
for a maximum of 18 years (to 2009), our last year of Medicare data, or until death.  The 
total sample size is N=41,158; age specific sample sizes are shown in Table 3.2.   
A secondary analysis of individuals aged 66 to 74 in 1992 was done using the 
information from birth certificates.  Birth certificate information in the UPDB is available 
from 1915 to 1921 and 1943 to the present; however, birth weight was not recorded until 
1947.  Because we are interested in birth weight and prematurity, all individuals used in 




(giving us complete fertility information).  Approximately 40% (n=4,142) of women and 
55% (n=6,192) of men in the young-old cohort have birth certificate records for all births.  
Individuals aged 66 and 74 in 1992 would have had to have their first birth at age 21 if 
they were the youngest members of the cohort and at age 29 if they were the oldest.  For 
females, the average age at first birth in the birth certificate sample is 2.5 years greater 
than those excluded (25.8 vs. 23.3, p<0.01) and for males it is 1.4 years greater than those 
excluded (26.9 vs. 25.5, p<0.01).  These requirements make this a select cohort, but the 
benefits of linking birth outcomes to later-life health trajectories makes this a valuable 




We are able to observe morbidity episodes from Medicare claims collected over 
time for each individual.  Health experience over time is measured by the Charlson 
Comorbidity Index (CCI) (Charlson, Pompei, Ales, & MacKenzie, 1987). The CCI was 
adapted for use with ICD-9 codes by Deyo et al. (Deyo, Cherkin, & Ciol, 1992) and 
Romano et al. (Romano, Roos, & Jollis, 1993). Deyo et al. adapted the index for use with 
ICD-9 diagnosis and procedure codes. Romano et al. included some diagnoses that were 
not in the original Charlson index. Both modifications were intended for use with the 
Medicare Part A records (Klabunde, Potosky, Legler, & Warren, 2000). Klabunde and 
colleagues (Klabunde, Warren, & Legler, 2002) created two indices, one for Medicare 
Part A records and one for Medicare Part B records. Introducing information from 
physician claims data significantly enhanced the index’s predictive value for the risk of 




SEER-Medicare Comorbidity macros 
(http://healthservices.cancer.gov/seermedicare/program/comorbidity.html).  We classified 
individuals into similar trajectory groups with respect to their morbidity patterns 
identified by their shared health experiences over time.  
The SEER-Medicare macro calculates the CCI with respect to cancer based on the 
Deyo adaptation of the index. Given that cancer originally was the index disease, it was 
not included as a comorbid condition in this SEER-Medicare program. Accordingly, we 
have added cancer as a comorbid disease. We identified specific episodes of the 
following 17 major morbidities conditions occurring during the interval 1992-2009 on a 
per annum basis that form the basis of the CCI.  Items are coded as “1” if they occur at 
any time during the year or “0” if they do not, and then weighted based upon their ability 
to predict mortality: 
1. Myocardial Infarction 
2. Congestive Heart Failure 
3. Peripheral Vascular Disease 
4. Cerebrovascular disease 
5. Dementia 
6. Chronic pulmonary disease 
7. Rheumatologic disease 
8. Peptic Ulcer Disease 
9. Mild Liver Disease 
10. Diabetes (mild to moderate) 
11. Diabetes with chronic complications 




13. Renal (kidney) disease 
14. Any malignancy 
15. Moderate or severe liver disease 
16. Metastatic Solid Tumor 
17. AIDS 
The independent variables used in the analysis can be partitioned into three domains: 





 All models controlled for age in 1992 centered on the mean for each sex and age 
group.  Widowhood is a frequent occurrence among individuals in this age range and 
may be linked to changes in health status (K. Williams & Umberson, 2004).  Time-
varying covariates are used to allow for altered shape of the trajectories due to loss of a 
spouse.  An indicator variable for each year was created for each year of observation and 
defined equal to “0” during all periods where the spouse is still alive and “1” during all 
periods where the spouse was deceased.   
 
Measures of Early-life Conditions 
Measures of age at parental death, childhood socioeconomic status, familial 
excess longevity (FEL), and religious participation are generated from the data within the 
UPDB. Death of a parent during childhood may have adverse effects on health later in 
life (Andersson, Hogberg, & Åkerman, 1996; Norton et al., 2011; Umberson & Chen, 
1994), and disruption of the family may affect the transition into adulthood, including 




UPDB and were used to construct eight categories of parental death.  The gender of the 
deceased parent may have different social and economic implications.  Therefore, two 
categories were created (one mother and one father) for each of the following 
circumstances related to parental death: mother/father died when child was under age 18, 
parent deceased after child was age 18 (reference category), and both parents deceased 
when child was under 18 (orphan).   
Childhood socioeconomic status may directly and indirectly influence marriage 
and reproductive success, timing of childbirth, and later-life comorbidity (Doblhammer & 
Oeppen, 2003; Geronimus & Korenman, 1992; D. Kuh & Ben-Shlomo, 2004).  
Childhood socioeconomic status is measured using usual occupation and industry 
information reported on a father’s death certificate for fathers who died in Utah and for 
whom we have a death certificate (deaths occurring from 1904 forward).  Occupational 
strings were converted to Nam-Powers socioeconomic (NP SES) scores, a measure of 
income and education based on occupational categories and range from 1 to 99, with 
higher scores being associated with higher socioeconomic status (Nam & Powers, 1983).  
NP SES scores were unavailable for approximately 20% of the sample.  Values for these 
individuals were imputed by substituting the mean plus a random number multiplied by 
the distribution of nonmissing values and an additional variable indicating missing 
values.  A large percentage of fathers from this era, a little over 30%, have the occupation 
“farmer,” resulting in a large heaping at the NP SES score of 40.  Farming may also 
confer a survival advantage related to life style factors (Gavrilov & Gavrilova, 2012), and 
a separate category was created for the occupation of farmer.   
To control for unobservable genetic and shared environmental effects, we used a 




statistic developed using deep genealogical data of multigenerational pedigrees drawn 
from the UPDB. We have published the development of this statistic (Kerber, O'Brien, 
Smith, & Cawthon, 2001) and have applied it to other life-span studies using UPDB 
(Garibotti, Smith, Kerber, & Boucher, 2006; Kerber, O'Brien, Boucher, Smith, & 
Cawthon, 2012; K. Smith et al., 2009).  At its foundation, the FEL is based on the 
assumption that family history of longevity follows Mendelian patterns of inheritance. To 
construct familial excess longevity, we first measure individual level excess longevity, 
defined as the difference between an individual’s attained age and the age to which that 
individual was expected to live according to a model that incorporates basic life-span 
predictors (sex, birth year). Expected longevity is estimated from an accelerated failure 
time (AFT) model, and excess longevity is simply the difference between expected and 
attained age. Expected longevity is based on the lognormal distribution and the AFT 
model was used because it provides a simple point estimate for duration that fits the 
observed data. Excess longevity is then extended to blood relatives who reached the age 
of 65 for each individual, a restriction that focuses on years less affected by external 
causes of death. The kinship coefficient, the probability that an individual shares a 
particular allele with another individual, is used as a weight in calculating familial excess 
longevity.  Averaging the excess longevities of all blood kin over 65 for each ego, with 
the appropriate weighting scheme, generates a point estimate of familial excess longevity.  
We have found that individuals with high FEL live longer and experience more healthful 
disease trajectories as they age (K. R.  Smith et al., 2012; K. R. Smith et al., 2009).   
Active affiliation with The Church of Jesus Christ of Latter-day Saints (LDS or 
Mormon) church is associated with increased life expectancy (Enstrom & Breslow, 2008) 




church are more likely to abstain from alcohol and tobacco use, fast once a month, and 
participate in church related social activities (Mineau, Smith, & Bean, 2002).  The UPDB 
contains information on baptism and endowment dates from family history records.  
These were used to classify individuals as active followers, inactive, or nonmembers.  
Individuals with an endowment date have agreed to live their lives following the doctrine 
of the Church and are considered active Church followers if endowed before age 40.  
Individuals with a baptism but no endowment date are considered inactive, and 
individuals with no baptism or endowment date are considered nonmembers (reference 
category).   
 
Measures of Fertility 
Fertility information in UPDB comes from a combination of information collected 
from Family Group Sheets obtained from the Utah Family History Library and linked 
vital records, including birth certificate data from 1915 – 1921 and 1943 to the present.  
All women in the sample have completed fertility by definition because they are required 
to survive to at least age 65 to be visible in the Medicare Claims data.  
Parity was measured with a set of dummy variables to indicate whether a woman 
had 1-2, 3-5, 6-8, or 9+ children.  On average, women in this sample had 4 children, and 
the category for 3-5 children was used as the reference category.  To measure the effects 
of early and late childbirth, we created dummy variables for the following categories: age 
at first birth before the age of 18, between ages 18 and 24, and after age 25, with 18-24 
used as the reference category.  There were very few men under the age of 18, and 
therefore this category was combined with the 18-24 category for men.  For age at last 




older.  A dummy variable is used to identify parents of multiples (twins).  Short birth 
intervals are defined as interbirth intervals less than 18 months, and long birth intervals 
are defined as interbirth intervals > 60 months (Conde-Agudelo, Rosas-Bermudez, & 
Kafury-Goeta, 2007).  Separate variables were created to identify individuals with one or 
more short or long interbirth interval.   
Infant mortality may be a marker for maternal health and adverse environments 
(McCormick, Shapiro, & Starfield, 1984).  Environments that lead to adverse health 
outcomes for the infant may also be risky for the parents.  Individuals losing one or more 
children during the first year of life will also be identified with a dummy variable.   
Birth certificate information in the UPDB is available from 1915 to 1921 and 
1943 to the present.  Birth certificates contain information on a mother’s marital status, 
prematurity, and birth weight (starting in 1947).  Using the information from the birth 
certificates, individuals are categoriezed as ever having a high birth weight baby (> 4,000 
grams) or low birth weight baby (<2,500 and carried 37+ weeks), which reflects the WIC 
Nutrition Risk Criteria (Medicine, 1996). Preterm birth was defined as the birth of an 
infant before 37 weeks of gestation.  Table 3.3 presents the descriptive statistics of all the 
measures by sex and age group.   
  
Constructing Morbidity Trajectories 
We seek to determine how reproductive history and health affect the likelihood of 
having a particular later-life comorbidity trajectory. Assessment of comorbidity 
trajectories is accomplished through the application of a finite mixture modeling 
approach that is currently available as a SAS procedure called PROC TRAJ through the 




2008; Jones & Nagin, 2007; Nagin & Tremblay, 2001). The group-based modeling 
approach allows for identification of distinct clusters of individual trajectories.   
Given the quickly changing health landscape of an aging population, all models 
are estimated within age-sex categories. The excess mortality risks of men and the 
generally higher rates of morbidity of women necessitate that we use sex-specific models. 
As age profoundly affects the risks of morbidity as encompassed in the CCI, as noted 
above, we divide the sample into two birth cohorts determined by their age at baseline.  
Because the response variable in this analysis is a weighted count of the number of 
comorbid conditions, a zero-inflated Poisson (ZIP) based model was used.  The ZIP 
model is an expansion of the Poisson model that corrects for overdispersion by 
accounting for more zeros than would be expected under a Poisson process.  Both the 
Poisson and censored normal distributions were also considered, but the ZIP model 
provided the best fit for our data.   
Trajectories were modeled for two to six groups as a quadratic function of time.  
Model fit was assessed using the Bayesian information criterion (BIC), the log likelihood 
plus a penalty for the number of parameters in the model.  There are situations where BIC 
score continues to increase as more groups are added, but the additional groups are not 
necessary to summarize the distinct features of the data in a parsimonious way (Nagin, 
2005).  Therefore, average posterior probability of assignment, odds of correct 
classification, and estimated group probabilities versus the proportion of the sample 
assigned to the group (Nagin, 2005) were also used to assess the selected model’s 
correspondence with the data.   
Nonrandom attrition leads to altered characteristics of the population over time 




a managed care plan during any period of a given year, our only source of truncation is 
death.  PROC TRAJ is used to simultaneously model the comorbidity trajectories and the 
probability of death, allowing the modeled probability of death to vary across trajectory 
groups.  Individuals in the analysis were required to be alive at time “1,” and therefore 
the probability of dropout during this period is zero for all trajectory groups.  All models 
accounted for nonrandom attrition due to death using the extension created by Haviland 
(Haviland, Jones, & Nagin, 2011; Zimmer, Martin, Nagin, & Jones, 2012).  This 
extension jointly models the trajectories with a model of the logit of the dropout 
probability, in this case death, by group that includes dependence on the prior period 
response until dropout and age.   
Trajectory group membership probabilities can vary as a function of time stable 
characteristics, or characteristics established before the observation periods (Jones & 
Nagin, 2007).   This third component jointly estimates a multinomial logit model that 
captures the effects of time stable characteristics on the probability of group membership.  
This makes it possible to test the effect of early-life conditions and fertility on the 
probability of membership in each group (Daniel S. Nagin & Odgers, 2010).  PROC 
TRAJ also allows for the inclusion of time-varying covariates measured during the 
observation time that may alter the shape of the observed trajectories, such as 
widowhood. 
A series of mediation analysis were conducted to test the hypothesis that fertility 
history mediated the relationship between early-life conditions and later-life health.  
Mediation tests used the Clogg test of differences in coefficients produced when fertility 





For each group, the following analyses were conducted.  First, we derived the 
basic trajectory groups in which comorbidity is a function of time only in order to select 
the best model.  Second, we fit a model with covariates from the demographic and early 
life conditions (ELCs).  Third, we fit a model with the covariates from the demographic, 
ELCs, and fertility domains.  All models accounted for nonrandom attrition due to death.  
In addition, we examined how ELCs in the probability of trajectory membership are 
mediated by timing of childbirth (age at first and last birth), preterm birth, and parity. 
   
Addressing Sample Selection 
The data requirements for selection into the sample, once married parous 
individuals who survived to age 66, had a spouse survive until they were age 50, and 
never enrolled in a managed care plan during the observation period, could lead to biased 
estimates because the data are not representative of the population.  To correct for the 
potential problem of selection, we use a Heckman two-stage modeling strategy 
(Heckman, 1979) performed using Stata 11.   
In the first stage, a probit model assesses factors leading to selection into the 
sample among all individuals (see Table 3.2).  The dependent variable is a dichotomous 
indicator of selection into the sample.  This equation is used to generate the inverse Mills 
ratio (IMR), which is a nonlinear transformation of the probit index and a decreasing 
function of the probability of selection (Fu, Winship, & Mare, 2004).  The IMR can be 
interpreted as the hazard of not being selected into the sample on which the comorbidity 
trajectories are based.  The independent variables used in the selection equation are 




must include variables that are more closely related to sample selection than the 
dependent variable in the substantive equation.   
Our sample selection is largely based on having complete information in UPDB 
and nonenrollment in a managed care organization (MCO).  Therefore, we selected 
independent variables for the selection equation that are closely related to these factors.  
Age in 1992 is derived from the CMS records.  The longitudinal information within the 
UPDB is more complete for individuals with a longer length of residence in the state of 
Utah.  The UPDB holds information on the birth place of individuals, and this was used 
to create an indicator variable for place of birth, Utah versus outside of Utah.  
Approximately 85% of the individuals selected into the sample were born in Utah, 
compared to 40% of those not selected into the sample.  Area level characteristics of an 
individual’s current place of residence may also predict selection into the sample.  
Information about an individual’s county of residence in 1992 was pulled from the 1990 
US Decennial Census.   
Table 3.4 shows that there are large differences in county level population and 
median family income between those selected and not selected into the final sample.  Of 
those selected into the final sample, 61% resided in the Wasatch Front region of Utah, 
compared to 48% of the nonselected individuals.  This contributes to the large difference 
in county level population between the groups because a larger proportion of individuals 
in the nonselected group resides in populous counties in California (such as LA county; 
population of 8.8 million in 1992).  In the second stage, trajectory models are estimated 
with the IMR from the first stage added as a covariate in the model, the goal being to 
account for possible sample selection bias in the final models.  The far right column in 




selection into the sample, with the exception of age in the equation for males aged 75 – 
84.  Age and being born in Utah were positively associated with selection into the 
sample, while median family income and population were negatively associated with 
selection into the sample for all genders and cohorts (with the age exception mentioned 
above).  A similar sample selection strategy was used by Gagnon et al. (2009) when 
examining the relationship between fertility and postreproductive survival.   
 
Results 
Trajectories of Comorbidity and Morbidity 
 The best fitting models for both males and females ages 66 – 74 (the young-old) 
in 1992 revealed six distinct groups of trajectory groups, while those for ages 75 – 84 (the 
old-old) showed five distinct groups. Figures 3.1- 3.4 show the predicted comorbidity 
trajectories by sex and age group.  The figures show the diversity of comorbidity 
experience over the 18 year period of follow-up (the youngest individuals are 84 years 
old at the end of the follow-up period).  To aid in the interpretation of results, trajectory 
groups have been labeled as follows: “robust”- characterized by the absence of comorbid 
conditions; “slow initiates”- individuals in this group begin the observation period with 
no comorbid conditions, but the number gradually increases over time; “accelerated 
initiates”- individuals in this group begin the observation period with no comorbid 
conditions but the number of conditions quickly increases over time and then decelerates 
during the last 2 years of the 18 year period; “chronic low”- characterized by the steady 
level of comorbidity over time; “ailing”- this group of individuals has moderate levels of 
comorbidity at baseline which steadily increase over time; “frail”- these individuals have 




In addition to using BIC as model selection criteria, several other measures were 
used to assess the correspondence of our models with the data (D. Nagin, 2005; Zimmer 
et al., 2012).  First, we calculated the average posterior probability (APP) of membership 
in group j for all individuals who are most likely to belong to that group.  The 
recommended criterion is that the APP for each group should exceed 0.70.  All selected 
models met this criterion, with APP ranging from 0.79 to 0.92.  Second, we compared 
estimated proportions of group membership generated by the maximum likelihood 
procedure to the actual proportion of the sample assigned to each group based on 
maximum posterior probability of group membership.  For this criterion, our models were 
satisfactory, with no more than a 4 point difference in any of the selected models.   
The shape of the trajectories is similar between males and females in their 
respective age groups, but the intercepts differ.  Individuals surviving the full 18 year 
period range in age from 83 to 91 in 2009.  For females in the young-old age category, 
trajectory membership is fairly evenly distributed among the robust (19.1%), slow initiate 
(18.8%), chronic (19.7%), and ailing (21.8%).  Compared to females, males have lower 
percentages of individuals in the robust (15.7%) and slow initiate (16.4%) groups, and 
higher percentages of individuals in the ailing (26.1%), accelerated initiate (15.3%), and 
frail groups (8%).  The frail category constitutes the lowest proportion of group 
membership for both males and females, 8% and 7.3%, respectively.  These findings are 
somewhat unexpected given the health-survival paradox, where females have worse 
health and males have higher mortality.  However, recently reported prevalence estimates 
support our findings.  The 2011 summary statistics for US adults reports higher 
prevalence rates of heart disease, hypertension, and diabetes for men (Schiller, Lucas, & 




2009 estimated that a higher percentage of men (49%) than women (42.5%) had two or 
more chronic conditions (conditions considered included hypertension, heart disease, 
diabetes, cancer, stroke, chronic bronchitis, emphysema, current asthma, and kidney 
disease; V. Fried, Bernstein, & Bush, 2012).   
 Individuals in the old-old cohort surviving the full 18 year period range in age 
from 92 to 101 in 2009.  For both sexes in this cohort, five distinct trajectory groups were 
identified.  The ailing category, with a CCI of approximately “1” at baseline that 
gradually increases over time, has the highest trajectory membership for both sexes, with 
29.7% of females and 35.3% of males falling into this category.  Compared to the young-
old, a smaller proportion of the old-old fall into the robust category (15.7% vs. 14.7% for 
males and 19.1% vs. 18.2% for females).  As expected, the robust in the old-old cohort 
do not maintain a disease free trajectory over the period of 18 years, with a predicted CCI 
of 0.74 for females and 1.5 for males in 2009.  While the pattern of this robust trajectory 
in the old-old cohort is similar to the pattern of the slow initiates in the young-old cohort, 
individuals in the old-old robust category have a slower rate of increase over time and 
end the period with a lower predicted CCI (the difference in CCI2009 is 0.82 for females 
and 0.44 for males).  Compared to the young-old, there is a near doubling in the 
proportion of frail females and a 50% increase for the males.  Another notable difference 
between the young-old and old-old frail trajectories is the maximum predicted CCI, 
which is higher in the young-old category for both sexes.  While the two cohorts are not 
directly comparable, the results suggest that there may be a decrease in the heterogeneity 
of morbidity patterns with age, with fewer categories in the older age groups.  The lower 
number of categories that fit the data may also be a function of the decreased sample size 




 We found six distinct trajectory groups for the male and female birth certificate 
samples.  The parameter estimates and estimated trajectory memberships were similar 
across samples (results not shown) with a slightly higher percentage in the robust group 
for both males and females compared to the full sample.  This is not unexpected given the 
younger age distribution of these subsamples.  The following trajectories were identified: 
robust (male=16.7%, female=20.3%); slow initiate (male=16.9%, female=19.2%); 
accelerated initiate (male=18.0%, female=14.3%); chronic low (male=16.1%, 
female=18.0%); ailing (male=25.2%, female=21.3%); and frail (male=6.9%, 
female=6.9%).   
 Figures 3.5 – 3.8 display the probability of death for each sex and age-group.  The 
probability of dropout due to death is modeled as a function of age and the comorbidity 
measurement in the previous year and is allowed to vary by trajectory group.  Mortality 
trajectories follow a similar hierarchy as the comorbidity trajectories, with the robust 
group generally having the lowest levels of mortality and the frail group having the 
highest.  Mortality in all groups rises with time, with the accelerated initiates having the 
fastest rate of increase in mortality over the 18 year period for the young-old cohort, and 
the ailing and initiates having the fastest rates of increase for females and males 
respectively in the old-old cohort.  Females have lower probabilities of death than males 
in their respective cohorts and comorbidity groups.  The young-old have lower 
probabilities of death than the old-old.  Both of these patterns are consistent with 
expected patterns of mortality in these age groups. 
 Widowhood altered the shape of the trajectory for some, but not all, trajectory 
groups.  In general, experiencing the death of a spouse led to an increase in the level of 




most impervious to the effects of widowhood, with few of the effects reaching 
significance.  Because these results are central to the hypothesis, they are not shown here 
but are available upon request. 
 
Fertility History and Later-Life Comorbidity 
 Once the best fitting trajectory models were selected, we jointly modeled 
multinomial logit models by sex and cohort, relating individual-level covariates to 
posterior probabilities to estimate the effects of ELCs and fertility on probability of group 
membership.  The first set of nested models included only ELCs and the results are not 
displayed in this paper, but they are available upon request.    Tables 3.5 – 3.8 display the 
odds ratios and 95% confident intervals for the full models that include demographic, 
ELCs, and fertility measures.  Comorbidity is the existence of multiple diseases.  Our 
results show that there are two groups in all models that escape transition into a comorbid 
state (two or more simultaneous conditions), the robust and chronic low. However, for 
ease of interpretation, the chronic low group will be referred to as a group with comorbid 
conditions.  The contrast group in all tables is the robust category, meaning that we are 
comparing the probability of membership in trajectory groups with comorbid conditions 
with the probability of membership in the group with no comorbid conditions.  All results 
discussed below are controlling for early-life events and demographic measures and, 
therefore, all results presented below are ceteris paribus.  Also, unless otherwise noted, 
the results highlighted below are significant at the 0.05 level. 
 For females in the young-old cohort, we do not find a significant association 
between parity and trajectory membership.  We do find a relationship between age at first 




birth between the ages of 19 and 24, young age at first birth (<18) nearly doubles the 
odds of being in the frail versus robust trajectory.  The results also suggest that young age 
at first birth increases the odds of being in the other categories with increased 
comorbidity, but the differences are merely suggestive.  Age at last birth confers a 
protective effect, with women having a last birth at age 35 or later having a decrease in 
the odds of being in a comorbid trajectory.  Females who have their last birth between the 
ages of 35 and 39 and after age 40 have a 24% and 25% (p=0.07) respective decrease in 
the odds of being in the frail versus robust group compared to females ending 
childbearing earlier.  There is a 33% decrease in the odds of being in the accelerated 
initiate group versus the robust trajectory for women having one or more infant deaths, 
but this pattern is not evident for other categories.   There is no evidence of an association 
between twinning, short birth intervals, long birth intervals, and later-life comorbidity 
trajectories for females in the young-old cohort.   
 Table 3.6 shows the results for females in the old-old cohort.  We find little 
association between parity and trajectory membership ceteris paribus for females in the 
old-old cohort with the exception of the frail group, where females having nine or more 
children are nearly twice as likely to be in the frail versus robust group.  The relationship 
between age at first birth and trajectory membership are similar to the patterns observed 
in the young-old cohort.  Females having their first birth during the teenage years are 
more likely to be in the chronic low, ailing, and frail versus robust groups.  Females in 
this cohort having their first birth after age 25 are less likely to be in the chronic low and 
frail categories.  Compared to females having their last birth before the age of 35, females 
having their last child after the age of 35 are more likely to be in the chronic low group 




a 24% decrease in the odds of being in the frail versus robust group.   As with the female 
young-old cohort, we find no association between trajectory membership and twinning, 
infant death, and short birth intervals ceteris paribus.  Having one or more long birth 
interval reduces the odds of being in any of the groups with more comorbid conditions 
versus the robust, with an 24%, 34%, 18%, and 27% respective decrease in the risk of 
being in the initiate, chronic low, ailing, and frail versus robust group (the difference in 
the magnitude of the effect across groups is not significant).    
We find no association between parity and trajectory membership for males in the 
young-old and old-old cohorts ceteris paribus.  Having a later age at first birth (over the 
age of 25 vs. less than 25) is protective for men in both cohorts.  Table 3.7 shows that for 
males in the young-old cohort, having their first birth at the age of 25 or older reduces the 
odds of being in the accelerated initiates, chronic low, ailing, and frail groups by a little 
over 20% for each group compared to the robust.  Table 3.8 shows that for males in the 
old-old cohort, having an older age at first birth is associated with an 18% and 29% 
reduction in the risk of being in the ailing and frail groups, respectively, compared to the 
robust group.  Males in the old-old cohort having their last child after the age of 40 have 
a 26% decrease in the odds of being in the ailing versus robust group.  We do not find an 
association between twinning, age at last birth, short birth intervals, long birth intervals, 
and infant deaths and group membership for males in these cohorts.   
 The results from of the birth certificate analysis are presented in Figures 3.9 and 
3.10.  Individuals included in these models were required to have birth certificate records 
for all births and, therefore, the results are based on a subsample of individuals in the 
young-old cohorts, with a higher percentage of the males from the full sample 




because, on average, men have an older age at first birth and are therefore more likely to 
meet the selection criteria.  All models controlled for early-life conditions and the fertility 
covariates presented used in the earlier models.  As with the previous analyses, the 
multinomial logit model relates individual-level covariates to posterior probabilities of 
trajectory group membership.  Models were run simultaneously with the trajectories, and 
the reference group is the robust, or group with the lowest number of comorbidities.  All 
models control for early-life conditions and demographic variables and were jointly 
modeled with mortality trajectories.   
We find that for females in the young-old cohort, having one or more high birth 
weight (defined as >4,000 g) children increases the odds of being in the chronic low, 
ailing, and frail versus the robust ceteris paribus by 39%, 60%, and 76%, respectively.   
Females having one or more preterm births (defined as <37 weeks gestation) have a 54% 
increase in the odds of being in the frail group versus the robust group.  We do not find 
an association between ever having a low birth weight (carried to term) baby and later-
life comorbidity trajectories for females.  For males in the birth certificate analysis, we 
find no association between premature offspring and group membership.  We do find that 
males having one or more high birth weight children have a 30% increase in the odds of 
being in the accelerated initiate versus the robust group.  Fathers of low birth weight 
babies are also more likely to be in the chronic low and ailing groups compared to the 
robust group.   
 To account for sample selection bias, the inverse Mills’ ratio (IMR) estimated 
from the probit model predicting selection into the sample was included in the analyses.  
Overall, the sample bias correction term (the IMR) has little effect on probability of 




with an increase in likelihood of being in the frail group for females in the young-old 
cohort (OR=1.3, 95% CI= 1.02, 1.67) and the ailing group for males in the old-old cohort 
(OR=1.38, 95% CI=1.07, 1.78).  Simply, individuals not predicted to be in the sample 
had a 30% and 38% increase in the odds of being in the frail and ailing groups for the 
young-old females and old-old males, respectively.  The beauty of the IMR term is that it 
simultaneously tests for and corrects selection bias.  Therefore, the selection bias present 
in models with significant terms has been corrected for by including the IMR in our 
models.  However, this should be interpreted with some caution because selection models 
are sensitive to the choice of covariates in the selection equation (Fu et al., 2004).   
 
The Mediating Effects of Fertility 
Mediation analyses were performed to test the mediating effects of fertility on 
early-life conditions.  Fertility variables were considered as possible intervening variables 
if they were significantly related to comorbidity group membership.  While there were 
few significant differences in coefficients, the percent change in the effects of the ELCs 
was small (ranging from 0.5% to 8%) and inconsistent.  Therefore, we concluded that 
fertility history did not significantly mediate the relationship between early-life 




 The purpose of this study was threefold.  First, we sought to identify distinct 
trajectories of comorbidity by sex for individuals in two age categories, the young-old 




membership.  Third, we tested the mediating role of fertility on the relationship between 
early-life conditions and comorbidity. We found that there are distinct heterogeneous 
patterns of comorbidity that range from a robust group, escaping major morbid conditions 
for the majority of the observation period, to a frail group characterized by high 
comorbidity throughout the entire period of observation.  Fertility history is associated 
with comorbidity trajectories after the age of 65 for both females and males when 
controlling for early-life circumstances, although it is clear that the fertility history has a 
greater impact on females.  These results provide some evidence that evolutionary “trade-
off” (H1), biological (H2), and social mechanisms (H4b, H4c) may all be associated with 
the observed relationship between fertility and later-life health.  While we found 
independent effects of early-life conditions on later-life comorbidity trajectories, we did 
not find robust evidence that fertility history is on the causal pathway between early-life 
conditions and later-life comorbidity.   
The observed relationships between parity, age at last birth and comorbidity group 
membership present evidence of a “trade-off” between fertility and aging for females in 
the young-old cohort.  Our finding of adverse effects at 9+ births is higher than the 5+ 
births reported in other studies of contemporary populations (Doblhammer, 2000; Grundy 
& Tomassini, 2005).  However, both studies top coded fertility at 5+ births.  Our findings 
support other studies suggesting that high levels of fertility are needed for a trade-off 
mechanism to operate (Gagnon et al., 2009; Kitagawa & Hauser, 1973).  We also find a 
consistent protective relationship between age at last birth and comorbidity group 
membership in the young-old cohort, with females having their last birth after age 35 
more likely to be in the robust group.  This is consistent with the prediction that older 




1997).  However, we do not see the same strong protective effect for females in the old-
old cohort.   
 Related to the evolutionary theories discussed above are the biological 
mechanisms through which fertility is linked to later-life comorbidity for women.  We 
did find some support for biological consequences to childbirth for women (H2), but we 
did not find evidence supporting the maternal depletion hypothesis or the link between 
low birth weight and comorbidity for women (Davey Smith et al., 2004; G. D. Smith et 
al., 1997).  High parity (9+ births) had an adverse effect on later-life health for females 
but not males, suggesting the costs of increased parity are biological.  Having at least one 
long birth interval had a protective effect on comorbidity later in life for females in the 
old-old cohort.  Long birth intervals have been linked to complications during 
reproductive years (Conde-Agudelo et al., 2007).  However, this study suggests that there 
are not long term consequences to widely spaced births for women in the old-old cohort.  
We do not find strong evidence in favor of the robust phenotype hypothesis (H3), 
which argues that fertility success is a marker for female health and vitality.  We find no 
association between short birth intervals and later-life comorbidity.  While the negative 
relationship between late age at last birth and comorbidity may be a marker for 
robustness, the hypothesized negative relationship between increased parity, shorter birth 
intervals, and twinning were not significant across trajectory groups and cohorts.  Other 
studies using this data from the UPDB have found evidence supporting the robust 
phenotype hypothesis (Robson & Smith, 2011, 2012).  However, that study uses a 
historical cohort of women that survive to age 50.  It is possible that twinning served as a 
selection filter, with only the most robust women giving birth to multiples during that 




contemporary sample with women giving birth during a period where medical 
intervention could increase the rate of survival for mothers of multiples.  Therefore, we 
are rejecting this hypothesis.  
 We do find evidence that social mechanisms explain some of the relationship 
between fertility and later-life health.  We do not find strong evidence of decreased 
comorbidity for individuals with more children, and therefore reject the social support 
hypothesis (H4a).  We find strong evidence supporting the association between age at 
first birth and comorbidity after age 65.  Young motherhood is related to adverse health 
outcomes for both cohorts in this study, and postponing parenthood is protective for 
males and females when controlling for early-life circumstances including childhood 
socioeconomic status.  This suggests that policy aimed at reducing teenage pregnancy 
may have significant effects on later-life health outcomes.  The adverse effect of low 
birth weight for males but not females and high birth weight of offspring for males and 
females suggests that adverse birth outcomes may be a marker of risky environments 
(Kramer, Séguin, Lydon, & Goulet, 2000).  We did not control for social environment at 
time of birth or current socioeconomic circumstance.  There are large socioeconomic 
disparities in perinatal and infant mortality, low birth weight, and preterm birth and, in 
the United States, these disparities are often related to racial/ethnic disparities (Kramer, 
1987; Kramer et al., 2000).  Future research should not only consider the early-life social 
environment, but the social environment throughout the life course.   
 Fertility decisions and outcomes are heavily influenced by social and historical 
circumstances, making it important to consider the historical context of these individuals’ 
lives.  The oldest members of the old-old cohort would have been born in 1908 and 




extending to 1965 for the youngest members of the cohort (assuming age at last birth is 
50).  The members of the young-old cohort would have initiated childbearing in 1933 and 
ended in 1974.  Infertility drugs would have been available for some individuals in these 
cohorts.  This means that parity and late age at last birth may not be completely 
biologically determined.  Individuals in both cohorts may have served during WWII, 
which may affect the timing of fertility.  Individuals in both cohorts would have been 
parous during the baby boom, when fertility rates peaked at 3.8 (Westoff, 1986).  
Members of the old-old cohort would also have been children during the 1918 influenza 
pandemic, an exposure that may have left them physiologically scarred, affecting both 
fertility and mortality.  A study by Smith et al. suggests that individuals exposed to 
influenza or pneumonia as children during the pandemic have lower ages at last birth and 
increased mortality (Ken R. Smith, Reed, Hanson, Mineau, & Fraser, 2012).   
 This study has several limitations that should be addressed in future studies of the 
relationship between fertility and later-life health.  First, these results are based on once 
married parous individuals.  Future studies should consider the relationship between 
nulliparity and later-life comorbidity for both men and women.  Second, we were unable 
to consider the role of all early-life and reproductive outcomes (including the number of 
sibling, number of sons and daughters, the proportion of offspring born prematurely, and 
the proportion of offspring born high/low birth weight) and later-life health.  Third, while 
we controlled for childhood SES, we were unable to control for SES at the time of birth 
and baseline.  We are currently in the process of creating files to begin these analyses.  
Fourth, sibling and spouse designs may improve understanding of the mechanisms 






 The paths to aging are heterogeneous and more research needs to be done to both 
characterize these different phenotypes and the factors that influence them.  Approaching 
this problem using the life course lens allows us to explore events that can directly or 
indirectly affect later-life health.  Understanding heterogeneity in the patterns of aging 
using a single period is an impossible endeavor because the biological functioning of an 
individual is dependent upon an array of circumstances from birth to death.  While early-
life conditions explain a portion of the heterogeneity in aging, midlife circumstances may 
also alter the trajectories of disease.  Parity, timing of childbearing, and birth outcomes of 
offspring are significantly related to later-life health outcomes.  The differences in risk 
factors between men and women suggest that evolutionary, biological, and social 
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Table 3.3.  Descriptive Statistics by Gender and Age Group 
 
 
Female 66-74 in 
1992 
Female 75 - 84 
in 1992 
Male 66-74 in 
1992 
Male 75 - 84 in 
1992 
 
N=12,190 N=10,099 N=11,349 N=7,520 
Early Life Conditions N(% of total sample) or Mean (SD) 
Father's Nam-Powers SES Score 49.37 (19.54) 47.4 (18.19) 49.0 (19.14) 47.09 (17.96) 
Father Farmer 3556 (29.2%) 3699 (36.6%) 3434 (30.3%) 2786 (37.1%) 
Father Missing SES 2982 (24.5%) 2416 (23.9%) 2620 (23.1%) 1754 (23.3%) 
Active LDS 6452 (52.9%) 5525 (54.7%) 5876 (51.8%) 4219 (56.1%) 
InActive LDS 2886 (23.7%) 2883 (28.6%) 2643 (23.3%) 1843 (24.5%) 
Non-LDS 2852 (23.4%) 1691 (16.7%) 2830 (24.9%) 1458 (19.4%) 
FEL Bottom 25% 2841 (23.3%) 2335 (23.1%) 2693 (23.7%) 1640 (21.8%) 
FEL Middle 50% 5321 (43.7%) 4525 (44.8%) 4869 (42.9%) 3648 (48.5%) 
FEL Top 25% 2662 (21.8%) 2653 (26.3%) 2554 (22.5%) 1757 (23.4%) 
FEL Missing 1366 (11.2%) 586 (5.8%) 1233 (10.9%) 475 (6.3%) 
Mother Died when Ego <18 721 (5.9%) 746 (7.4%) 682 (6.0%) 555 (7.4%) 
Mother Died when Ego 18+ 11379 (93.4%) 9255 (91.6%) 10583 (93.3%) 6906 (91.8%) 
Father Died when Ego <18 1060 (8.7%) 943 (9.3%) 951 (8.4%) 714 (9.5%) 
Father Died when Ego 18+ 11040 (90.6%) 9058 (89.7%) 10314 (90.9%) 6747 (89.7%) 
Both Parents Died Before 18 90 (0.7%) 98 (1%) 84 (0.7%) 59 (0.8%) 
Fertility History         
Children 1-2 3004 (24.6%) 3138 (31.1%) 2533 (22.3%) 2104 (28.0%) 
Children 3-5 6798 (55.8%) 5287 (52.4%) 6605 (58.2%) 4087 (54.4%) 
Children 6-8 2061 (16.9%) 1410 (14.0%) 1934 (17.0%) 1135 (15.1%) 
Children 9+ 327 (2.7%) 264 (2.6%) 277 (2.4%) 194 (2.6%) 
Infant Death (Y/N) 730 (6.0%) 757 (7.5%) 637 (5.6%) 527 (7.0%) 
Short Birth Interval (Y/N) 3380 (27.7%) 2238 (22.2) 3489 (30.7%) 1707 (22.7%) 
Long Birth Interval (Y/N) 5201 (42.7%) 4684 (46.4%) 4568 (40.3%) 3513 (46.7%) 
Mother/Father of Twin 580 (4.8%) 489 (4.8%) 486 (4.3%) 370 (4.9%) 
Age at First Bith Less than 18 391 (3.2%) 316 (3.1%) n/a n/a 
Age at First Birth 18 - 24 8590 (70.5%) 5871 (58.1%) 5815 (51.2%) 2687 (35.7%) 
Age at First Birth 25+ 3209 (26.3%) 3912 (38.7%) 5534 (48.8%) 4833 (34.3%) 
Age at Last Birth 35 - 39 1848 (15.2%) 3105 (30.8%) 2864 (25.2%) 2188 (29.1%) 
Age at Last Birth >=40 3827 (31.4%) 2369 (23.5%) 2864 (25.2%) 2995 (39.8%) 
Age 70.09 (2.57) 79.00 (4.76) 70.0 (2.56) 78.6 (2.78) 
Information from Utah Birth Certificates* 
At least 1 High Birth Weight Baby 668 (16.1%)   1126 (18.8%)   
At least 1 Low Birth Weight Baby 283 (6.8%) 
 
434 (7.0%) 
 At Least One Preterm Birth 572 (13.8%) 
 
942 (15.2%) 
 Adult Measures        
Spouse Alive at Baseline 9523 (78.1%) 5023 (49.7%) 10913 (96.2%) 6662 (88.6%) 
*Female N=4142; Male N=6192 
Note: Age 66-74 in 1992 with birth certificate data on all births, making this a select 
sample. Females are younger (avg age=69, range 66 - 74) and had to have their first birth 
after age 20 (1947 is the first year BC available).  Males are younger and had to have 






Table 3.4.  Sample Selection Means by Gender and Age 
  Mean (StdDev) Mean (StdDev) 
Selection 
Model 




(N=12,190) Probit P-value 
Age  in  1992 69.81(2.55) 70.09(70.09) 0.024 <0.001 
Born in Utah 0.39(0.49) 0.85(0.85) 1.186 <0.001 
1990 County Med Family Income 
(Unit=10,000) 3.35(0.53) 3.28(3.28) -0.085 <0.001 
1990 County Population (Unit=100,000) 5.87(12.4) 3.63(3.63) -0.018 <0.001 








(N=10,099) Probit P-value 
Age  in  1992 78.95(2.79) 79(2.84) 0.01 0.01 
Born in Utah 0.41(0.49) 0.83(0.38) 1.10 <0.001 
1990 County Med Family Income 
(Unit=10,000) 3.33(0.55) 3.26(0.42) -0.12 <0.001 
1990 County Population (Unit=100,000) 6.07(13.26) 3.65(6.34) -0.01 <0.001 








(N=11,349) Probit P-value 
Age  in  1992 69.79(2.56) 69.97(2.56) 0.02 <0.001 
Born in Utah 0.4(0.49) 0.86(0.34) 1.24 <0.001 
1990 County Med Family Income 
(Unit=10,000) 3.34(0.57) 3.28(0.43) -0.10 <0.001 
1990 County Population (Unit=100,000) 6.09(13.52) 3.77(6.56) 0.00 <0.001 




Male  Age 75 - 84 
Excluded 
(N=29,211) Included (N=7,520) Probit P-value 
Age  in  1992 78.67(2.75) 78.63(2.78) 0.00 0.61 
Born in Utah 0.4(0.49) 0.84(0.37) 1.16 <0.001 
1990 County Med Family Income 
(Unit=10,000) 3.28(0.57) 3.26(0.43) -0.08 <0.001 
1990 County Population (Unit=100,000) 5.63(13.1) 3.71(7.08) -0.01 <0.001 
Missing 1990 Census Info 1% 0.30% -0.59 <0.001 






Table 3.5.  Effects of Early Life Conditions and Fertility on Comorbidity Trajectory 





Initiates Chronic Low Ailing Frail 
18.8% 13.3% 19.7% 21.8% 7.3% 
Early Life Conditions Odd Ratio (95% CI) 
Age in 1992  2.47(1.88,3.26) 2.54(1.89,3.41) 3.52(2.71,4.58) 3.01(2.34,3.87) 3.16(2.24,4.45) 
Active Member of LDS Church 0.76(0.61,0.94) 0.55(0.44,0.68) 0.72(0.58,0.88) 0.45(0.37,0.54) 0.47(0.37,0.61) 
Inactive Member of LDS 
Church 0.84(0.66,1.06) 0.57(0.45,0.73) 0.78(0.62,0.98) 0.59(0.48,0.73) 0.56(0.42,0.73) 
Non-Member (reference) 1 1 1 1 1 
Father's NP SES (unit=10) 1.02(0.98,1.05) 0.98(0.94,1.02) 1.01(0.97,1.04) 0.99(0.96,1.03) 0.96(0.91,1) 
Father Farmer 1.01(0.85,1.2) 0.8(0.67,0.96) 1.1(0.93,1.29) 0.79(0.68,0.92) 0.74(0.6,0.93) 
Missing SES 0.91(0.76,1.09) 0.91(0.76,1.1) 1.08(0.91,1.28) 0.85(0.73,1.01) 1.08(0.87,1.34) 
FEL in Bottom Quartile 1.19(0.99,1.44) 1.38(1.14,1.67) 1.24(1.04,1.48) 1.44(1.22,1.69) 1.27(1.02,1.59) 
FEL in Mid 50% (reference) 1 1 1 1 1 
FEL in Top Quartile 0.79(0.67,0.94) 0.75(0.62,0.91) 0.71(0.61,0.84) 0.58(0.49,0.68) 0.7(0.56,0.87) 
FEL Missing 0.97(0.74,1.27) 0.75(0.57,1) 0.84(0.64,1.09) 0.56(0.44,0.72) 0.45(0.32,0.63) 
Orphaned before Age 18 2.39(0.91,6.29) 1.78(0.62,5.14) 1.46(0.53,4.05) 2.62(1.08,6.36) 3.87(1.44,10.4) 
Mother Died before Child 18 1.1(0.82,1.49) 1.28(0.94,1.73) 1.11(0.83,1.48) 1.24(0.95,1.63) 1.48(1.05,2.1) 
Father Died before Child 18 1.12(0.87,1.45) 1.38(1.07,1.78) 1.12(0.88,1.43) 1.24(0.99,1.56) 1.32(0.98,1.78) 
Both Parents Alive at 18 
(reference) 1 1 1 1 1 
Fertility           
1-2 Children 0.87(0.72,1.06) 1.07(0.88,1.31) 0.89(0.74,1.06) 0.95(0.8,1.13) 1.13(0.9,1.42) 
3-5 Children (reference) 1 1 1 1 1 
6-8 Children 1.09(0.87,1.35) 1.04(0.82,1.31) 1.1(0.9,1.36) 1.16(0.95,1.42) 1.1(0.83,1.45) 
9+ Children 0.86(0.52,1.43) 1.06(0.65,1.74) 1.01(0.65,1.58) 1.2(0.79,1.84) 0.96(0.51,1.77) 
Age at First Birth < 18 1.48(0.97,2.25) 1.48(0.96,2.3) 1.33(0.88,2.01) 1.44(0.98,2.12) 1.94(1.2,3.13) 
Age at First Birth 18 - 24 (ref) 1 1 1 1 1 
Age at first Birth >= 25 1.04(0.88,1.24) 0.86(0.71,1.03) 0.93(0.79,1.1) 0.86(0.74,1.02) 1.06(0.86,1.31) 
Age at Last Birth 35 - 39 0.85(0.71,1.02) 0.83(0.68,1.01) 0.81(0.68,0.97) 0.82(0.69,0.97) 0.76(0.61,0.96) 
Age at Last Birth >= 40 0.65(0.5,0.84) 0.8(0.61,1.05) 0.82(0.65,1.04) 0.66(0.52,0.83) 0.75(0.54,1.03) 
Mother of Twins 1.17(0.84,1.62) 0.95(0.66,1.38) 0.96(0.69,1.32) 1.12(0.83,1.51) 1.01(0.67,1.54) 
One or More Short Birth 
Intervals 1.01(0.85,1.19) 1.11(0.93,1.33) 0.92(0.78,1.08) 1.03(0.88,1.21) 1.06(0.85,1.31) 
One or More Long Birth 
Intervals 1.01(0.87,1.19) 1.06(0.9,1.26) 0.93(0.8,1.09) 1.02(0.88,1.17) 0.97(0.79,1.19) 
One or More Infant Deaths 0.93(0.69,1.24) 0.67(0.47,0.95) 0.83(0.62,1.1) 1.02(0.79,1.32) 1.13(0.8,1.6) 
Sample Selection Bias 
     IMR 1.13(0.92,1.39) 1.03(0.82,1.28) 1.06(0.86,1.29) 1.17(0.96,1.41) 1.3(1.02,1.67) 
 
Note: Results shown in Table 3.5 are controlling for widowhood and jointly modeled 




Table 3.6.  Effects of Early Life Conditions and Fertility on Comorbidity Trajectory 
Group Membership versus Robust Group (18.2%): Women Ages 75 – 84 in 1992 
 
 
Initiates Chronic Low Ailing Frail 
21.6% 29.7% 16.9% 13.6% 
Early Life Conditions Odd Ratio (95% CI) 
Age in 1992  1.84(1.38,2.44) 3.89(2.89,5.24) 2.77(2.16,3.55) 2.95(2.21,3.95) 
Active Member of LDS Church 1.05(0.82,1.33) 0.83(0.65,1.07) 0.89(0.72,1.1) 0.93(0.72,1.19) 
Inactive Member of LDS Church 1.12(0.87,1.45) 0.79(0.6,1.03) 0.97(0.78,1.22) 1.05(0.81,1.37) 
Non-Member (reference) 1 1 1 1 
Father's NP SES (unit=10) 1.02(0.98,1.07) 1.02(0.98,1.07) 1.02(0.98,1.06) 1(0.95,1.04) 
Father Farmer 0.93(0.78,1.12) 1.07(0.87,1.31) 1.14(0.96,1.34) 0.93(0.77,1.13) 
Missing SES 1.01(0.82,1.23) 1.07(0.86,1.34) 1.11(0.92,1.33) 1.08(0.87,1.34) 
FEL in Bottom Quartile 1.44(1.17,1.77) 1.41(1.12,1.76) 1.59(1.33,1.91) 1.6(1.3,1.97) 
FEL in Mid 50% (reference) 1 1 1 1 
FEL in Top Quartile 0.77(0.64,0.91) 0.83(0.69,1.01) 0.65(0.56,0.77) 0.61(0.51,0.75) 
FEL Missing 0.91(0.63,1.3) 1.11(0.77,1.6) 0.81(0.58,1.11) 0.78(0.53,1.14) 
Orphaned before Age 18 0.88(0.42,1.85) 0.97(0.42,2.23) 1.29(0.68,2.43) 0.78(0.32,1.91) 
Mother Died before Child 18 1.16(0.86,1.56) 1.31(0.96,1.78) 0.99(0.75,1.3) 1.35(1,1.81) 
Father Died before Child 18 1.19(0.91,1.57) 1.15(0.86,1.54) 1.27(1,1.61) 1.24(0.94,1.63) 
Both Parents Alive at 18 (reference) 1 1 1 1 
Fertility         
1-2 Children 0.98(0.8,1.21) 0.96(0.77,1.2) 0.9(0.75,1.08) 0.89(0.72,1.11) 
3-5 Children (reference) 1 1 1 1 
6-8 Children 1.01(0.79,1.31) 0.93(0.7,1.23) 1.22(0.97,1.53) 1.15(0.88,1.52) 
9+ Children 0.77(0.43,1.38) 0.68(0.36,1.29) 1.17(0.73,1.89) 1.98(1.18,3.32) 
Age at First Birth < 18 1.45(0.84,2.49) 1.85(1.05,3.24) 1.97(1.24,3.13) 2.03(1.23,3.36) 
Age at First Birth 18 - 24 (ref) 1 1 1 1 
Age at first Birth >= 25 0.86(0.72,1.03) 0.77(0.63,0.94) 0.9(0.77,1.06) 0.78(0.64,0.95) 
Age at Last Birth 35 - 39 1.07(0.87,1.31) 1.38(1.11,1.72) 1.01(0.84,1.21) 1.11(0.9,1.37) 
Age at Last Birth >= 40 1.13(0.89,1.45) 1.34(1.03,1.75) 0.89(0.71,1.11) 0.76(0.58,0.99) 
Mother of Twins 1.08(0.76,1.54) 0.96(0.64,1.44) 1.02(0.74,1.4) 1.19(0.83,1.71) 
One or More Short Birth Intervals 1.04(0.85,1.26) 0.83(0.66,1.04) 1.03(0.87,1.23) 0.89(0.72,1.1) 
One or More Long Birth Intervals 0.76(0.63,0.91) 0.66(0.54,0.8) 0.82(0.7,0.96) 0.73(0.61,0.88) 
One or More Infant Deaths 0.78(0.57,1.06) 0.84(0.6,1.17) 1(0.78,1.29) 1.07(0.8,1.44) 
Sample Selection Bias 
    IMR 0.95(0.75,1.21) 1.13(0.87,1.45) 1.12(0.9,1.39) 1.12(0.87,1.44) 
 
Note: Results shown in Table 3.6 are controlling for widowhood and jointly modeled 




Table 3.7.  Effects of Early Life Conditions and Fertility on Comorbidity Trajectory 





Initiates Chronic Low Ailing Frail 
16.4% 15.3% 18.5% 26.1% 8% 
Early Life Conditions Odd Ratio (95% CI) 
Age in 1992  1.4(1.01,1.94) 1.64(1.2,2.23) 2.33(1.73,3.15) 3.14(2.39,4.12) 3.41(2.36,4.91) 
Active Member of LDS Church 0.76(0.59,0.98) 0.55(0.44,0.7) 0.82(0.65,1.03) 0.48(0.39,0.59) 0.4(0.31,0.52) 
Inactive Member of LDS Church 0.66(0.5,0.86) 0.7(0.55,0.91) 0.75(0.58,0.97) 0.59(0.47,0.74) 0.45(0.34,0.6) 
Non-Member (reference) 1 1 1 1 1 
Father's NP SES (unit=10) 0.98(0.94,1.02) 1.01(0.97,1.05) 0.99(0.95,1.03) 1.02(0.98,1.05) 1.02(0.97,1.07) 
Father Farmer 0.99(0.81,1.2) 1.05(0.87,1.27) 0.9(0.75,1.07) 1.13(0.96,1.33) 1.06(0.84,1.32) 
Missing SES 1.05(0.85,1.3) 1.1(0.9,1.35) 0.96(0.79,1.18) 1.05(0.88,1.26) 1.14(0.9,1.44) 
FEL in Bottom Quartile 1.2(0.96,1.49) 1.19(0.97,1.47) 1.28(1.05,1.57) 1.37(1.14,1.64) 1.3(1.03,1.65) 
FEL in Mid 50% (reference) 1 1 1 1 1 
FEL in Top Quartile 0.73(0.6,0.88) 0.71(0.59,0.86) 0.68(0.57,0.82) 0.66(0.56,0.78) 0.6(0.48,0.76) 
FEL Missing 0.86(0.63,1.17) 0.88(0.65,1.18) 0.87(0.65,1.17) 0.55(0.42,0.72) 0.5(0.35,0.71) 
Orphaned before Age 18 0.27(0.09,0.79) 0.57(0.24,1.34) 0.58(0.25,1.35) 0.72(0.37,1.41) 0.73(0.29,1.84) 
Mother Died before Child 18 1.21(0.86,1.7) 1.18(0.85,1.64) 1.14(0.82,1.58) 1.21(0.9,1.62) 1.12(0.76,1.65) 
Father Died before Child 18 1.14(0.85,1.54) 1.17(0.88,1.55) 1.08(0.82,1.43) 1.25(0.97,1.6) 1.07(0.77,1.5) 
Both Parents Alive at 18 
(reference) 1 1 1 1 1 
Fertility           
1-2 Children 1.04(0.82,1.3) 1.17(0.94,1.46) 1.14(0.92,1.41) 1.01(0.83,1.23) 1.25(0.96,1.61) 
3-5 Children (reference) 1 1 1 1 1 
6-8 Children 0.84(0.65,1.08) 1.04(0.82,1.32) 0.91(0.72,1.15) 0.91(0.74,1.13) 1.19(0.9,1.58) 
9+ Children 0.63(0.37,1.08) 0.87(0.53,1.42) 0.63(0.37,1.05) 0.71(0.45,1.1) 0.77(0.41,1.47) 
Age at First Birth <25 (ref) 1 1 1 1 1 
Age at first Birth >= 25 0.88(0.74,1.05) 0.79(0.66,0.93) 0.78(0.66,0.92) 0.74(0.63,0.86) 0.78(0.63,0.95) 
Age at Last Birth 35 - 39 0.99(0.8,1.23) 1.15(0.93,1.42) 0.98(0.8,1.2) 1.02(0.85,1.22) 1.12(0.88,1.43) 
Age at Last Birth >= 40 1.04(0.79,1.37) 1.21(0.93,1.57) 0.88(0.68,1.14) 1.09(0.87,1.38) 0.94(0.69,1.29) 
Father of Twins 0.94(0.64,1.4) 0.95(0.65,1.39) 1.2(0.85,1.71) 1.01(0.72,1.4) 1.13(0.73,1.75) 
One or More Short Birth 
Intervals 1.11(0.92,1.33) 0.94(0.78,1.13) 1.17(0.98,1.4) 1.01(0.86,1.18) 1.13(0.91,1.41) 
One or More Long Birth 
Intervals 1.08(0.9,1.29) 0.98(0.82,1.17) 1.17(0.98,1.39) 0.97(0.83,1.13) 1.06(0.86,1.31) 
One or More Infant Deaths 0.83(0.59,1.18) 1.07(0.78,1.47) 0.83(0.6,1.14) 0.85(0.64,1.14) 0.85(0.57,1.25) 
Sample Selection Bias 
     IMR 0.89(0.7,1.14) 0.9(0.71,1.13) 0.91(0.73,1.13) 1.06(0.87,1.29) 0.98(0.75,1.28) 
 
Note: Results shown in Table 3.7 are controlling for widowhood and jointly modeled 




Table 3.8.  Effects of Early Life Conditions and Fertility on Comorbidity Trajectory 
Group Membership versus Robust Group (14.7%): Men Ages 75 – 84 in 1992 
 
 
Initiates Ailing Chronic Low Frail 
17.4% 35.3% 20.2% 12.5% 
Early Life Conditions Odd Ratio (95% CI) 
Age in 1992  1.6(1.09,2.34) 2.24(1.65,3.05) 2.12(1.5,3) 2.82(1.94,4.1) 
Active Member of LDS Church 0.81(0.6,1.07) 0.78(0.62,1) 0.8(0.61,1.05) 0.72(0.53,0.96) 
Inactive Member of LDS Church 1.01(0.73,1.4) 0.98(0.75,1.28) 0.97(0.71,1.31) 0.97(0.7,1.34) 
Non-Member (reference) 1 1 1 1 
Father's NP SES (unit=10) 1(0.94,1.06) 1(0.95,1.04) 1.01(0.95,1.06) 0.96(0.9,1.02) 
Father Farmer 0.95(0.75,1.21) 0.94(0.77,1.14) 0.95(0.76,1.19) 1.09(0.85,1.38) 
Missing SES 1.06(0.81,1.38) 0.85(0.68,1.06) 0.9(0.7,1.16) 0.98(0.74,1.29) 
FEL in Bottom Quartile 1.38(1.06,1.81) 1.7(1.36,2.13) 1.28(0.99,1.66) 1.89(1.46,2.46) 
FEL in Mid 50% (reference) 1 1 1 1 
FEL in Top Quartile 0.8(0.63,1.01) 0.77(0.64,0.94) 0.91(0.73,1.14) 0.67(0.52,0.87) 
FEL Missing 0.71(0.45,1.11) 0.76(0.53,1.1) 0.99(0.66,1.49) 0.84(0.53,1.33) 
Orphaned before Age 18 1.16(0.34,3.94) 1.28(0.5,3.24) 0.67(0.18,2.45) 0.43(0.1,1.84) 
Mother Died before Child 18 1.14(0.78,1.68) 1.36(0.99,1.87) 1.11(0.77,1.61) 1(0.66,1.51) 
Father Died before Child 18 1.01(0.73,1.39) 0.97(0.75,1.27) 0.79(0.57,1.09) 1(0.72,1.39) 
Both Parents Alive at 18 (reference) 1 1 1 1 
Fertility         
1-2 Children 1.01(0.76,1.34) 0.95(0.75,1.2) 1.07(0.82,1.39) 0.97(0.73,1.29) 
3-5 Children (reference) 1 1 1 1 
6-8 Children 0.81(0.59,1.12) 1.14(0.88,1.47) 0.89(0.66,1.19) 0.77(0.55,1.07) 
9+ Children 0.82(0.43,1.57) 0.81(0.47,1.4) 0.76(0.41,1.4) 0.61(0.31,1.2) 
Age at First Birth <25 (ref) 1 1 1 1 
Age at first Birth >= 25 0.97(0.77,1.23) 0.82(0.68,1) 0.86(0.69,1.07) 0.71(0.56,0.9) 
Age at Last Birth 35 - 39 0.96(0.72,1.28) 0.85(0.67,1.08) 0.79(0.6,1.04) 0.73(0.54,0.98) 
Age at Last Birth >= 40 0.94(0.67,1.31) 0.74(0.56,0.97) 0.94(0.69,1.28) 0.81(0.58,1.12) 
Father of Twins 0.86(0.54,1.37) 0.71(0.48,1.05) 1.25(0.84,1.86) 1.12(0.71,1.74) 
One or More Short Birth Intervals 1.16(0.9,1.51) 0.92(0.74,1.14) 0.98(0.76,1.25) 1.15(0.88,1.49) 
One or More Long Birth Intervals 1.11(0.88,1.39) 1.05(0.87,1.26) 1.12(0.9,1.38) 1.1(0.87,1.39) 
One or More Infant Deaths 1.03(0.69,1.55) 1.27(0.92,1.76) 1.01(0.69,1.49) 0.96(0.64,1.46) 
Sample Selection Bias 
    IMR 1.21(0.89,1.64) 1.38(1.07,1.78) 1.15(0.86,1.54) 0.98(0.71,1.36) 
 
Note: Results shown in Table 3.8 are controlling for widowhood and jointly modeled 



















Figure 3.3. Comorbidity trajectories for males ages 66 – 74 in 1992. 






Figure 3.4.  Comorbidity trajectories for males ages 75 – 84 in 1992. 























Figure 3.8.  Morbidity trajectories for males ages 75 – 84 in 1992. 






Figure 3.9.  Female birth certificate results: Ages 66 – 74 in 1992.  Controlling for early-
life conditions, fertility variables, demographic characteristics, and jointly modeled with 
mortality trajectories.  Birth certificate sample (N=4,214) 


































































































































































Figure 3.10.  Male birth certificate results: Ages 66 – 74 in 1992. Controlling for early-
life conditions, fertility variables, demographic characteristics, and jointly modeled with 



















































































































































































Mortality is the quintessential measure of the health of a population, and large 
gains in human life expectancy over the past 150 years are evidence of the important 
relationship between social context and health.  While there is certainly variability in 
longevity between populations, there is also wide variation in longevity within 
populations.  Understanding the determinants of this heterogeneity is essential to 
understanding the processes of aging and health of a population.  But how much of this 
variation is determined by genetic factors and how much is determined by the 
environment?  While the question of heritability of longevity is not new, with heritability 
estimates of longevity ranging from 0 to 0.3 (Kerber, O'Brien, Smith, & Cawthon, 2001), 
we seek to determine if heritability estimates vary between subpopulations and explore 
the possibility of gene-environment interactions (GxE).  By examining sources of 
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variation in heritability estimates, we can illuminate factors that modify the expression of 
genetic predisposition in a population.   
We will investigate heterogeneity in the genetic basis of longevity by assessing 
the phenotypic correlation between relatives.  Variance components and heritability 
values will be generated using a large genealogical database with information on family 
structure as well as measures of the broader environment.   This study will examine the 
relationship between social context and the amount of additive genetic variance in adult 
life-span and exceptional longevity using data from the Utah Population Database 
(UPDB), a rich source of linked population-based information for demographic, genetic, 
and epidemiological studies.  The sample used in this study consists of 20,120 individuals 
from 802 three generation pedigrees.  This analysis has two goals: 1) estimate the 
heritability of longevity after age 30 as well as exceptional longevity in a population 
using methods designed for use in multigenerational pedigree information; 2) test for 
differences in heritability estimates of life-span in populations stratified by environmental 
exposure.   
  
Background 
Heritability of Longevity 
Over the past few decades, demographers have broadened the focus of work in the 
demography of aging from a population aging perspective (i.e., measures of change in 
population age structure) to include a perspective that integrates health and biological 
explanations with traditional demographic and social theories of aging to explain 
heterogeneity in health and mortality within and between populations (Olshansky, 




widely accepted that life-span is determined by a combination of genetic, social and 
physical environment, and stochastic factors, the interdependent and dynamic role of 
genes and environment is still not well understood.  This may be partially due to fears of 
genetic determinism within the field of sociology (Shostak & Freese, 2010), the divergent 
paths of genetics and demography (Adams, 1990), and the difficulty of assessing the role 
of genes and environment biomarker data.    
Longevity is a complex trait, determined by a multiplicity of genetic and 
environmental factors, each of which contributes to a potentially small amount of 
phenotypic variation.  The genetic variation that is the natural background is a shortened 
life-span (relative to exceptional longevity) and exceptional longevity is the result of 
mutations.  Genes affecting longevity have been parsed into two categories described as 
gerontogenes: genes that have a negative effect on longevity and longevity-assurance 
genes that promote longevity (Christensen, Johnson, & Vaupel, 2006).  Findings from the 
New England Centenarian Study (NECS) have suggested that supercentenarians do not 
lack gerontogenes, but have longevity assurance genes that can counter the deleterious 
effects of genes and environment as well as slow the rate of aging and lead to delayed 
onset of age-related disease (Sebastiani et al., 2012).  It is also believed that longevity 
mutations increase the ability to handle stress and robustness (Christensen et al., 2006).  
The proportion of variation in life-span due to genes is moderate, which can be illustrated 
by the fact that there is variation in life-span between monozygotic twins (Herskind et al., 
1996).   
In summary, longevity is determined by a complex relationship between both 
genes and environment.  For a more complete understanding of population heterogeneity 




contribution of genes and environment within a population toward explaining variation in 
adult mortality, but uncover the factors that influence patterns of variation within the 
population.   
At the most basic level, phenotypic variation can be partitioned into additive 
genetic variance and general environmental variance.  Additive genetic variance is the 
deviation from the average phenotype that is due to the inheritance of a particular allele 
and that allele’s effect on the phenotype.  General environmental variance can then be 
described as the remaining variance that cannot be attributed to genes.  The proportion of 
variation due to inheritance of a particular allele is not fixed across all environments 
because the relationship between genotype and phenotype may vary by environment, a 
phenomenon known as phenotypic plasticity.  Narrow sense heritability is a population 
level statistic that describes the amount of total phenotypic variation (VT) that can be 
attributed to additive genetic variation (VA) in the population (h
2 
= VA/VT).   The 
polygenic model can be used to partition variation into genetic and residual 
environmental effects.  Because it is a population level statistic, it is important to keep in 
mind that it not a property of individual traits.  When h
2
equals zero, it indicates that all 
phenotypic variation within a population can be explained by individual differences, 
while an h
2 
of 1 indicates that all the phenotypic variation is explained by genetic 
differences.  This is not to say that high heritability suggests little environmental effect on 
the phenotype.  When h
2
 is elevated the environment may uniformly contribute to the 
expression of the trait and therefore contribute little to differences between people.  It has 
been shown that heritability of traits can vary across subpopulations (Boardman, 2009; 
Boardman et al., 2012; Rowe, Almeida, & Jacobson, 1999).  But how much of the 




There is evidence of the presence of familial clustering of longevity over many 
generations and across diverse populations, suggesting that there is a genetic or familial 
component to successful aging and longevity (Christensen et al., 2006; Finch & Tanzi, 
1997; Herskind et al., 1996; Kerber et al., 2001; Perls, Kunkel, & Puca, 2002).  The 
longevity literature has described the genetic and environmental contribution to mortality 
as being divided into one-third and two-third proportions, respectively (C. E. Finch & 
Tanzi, 1997; Siegel, 2011).  It has also been suggested that 50% of the variation in life-
span after age 30 can be ascribed to attributes (genetic and nongenetic) that are fixed 
prior to that age (Yashin & Iachine, 1997), and that genetics plays a stronger role with 
advancing age (Hjelmborg et al., 2006; Montesanto, Dato, Bellizzi, Rose, & Passarino, 
2012; Vaupel et al., 1998; see J. W. Rowe and Kahn (1997) for a dissent from this view).  
If the proportion of variation in life-span that can be explained by genetic factors varies 
by age, is it also conditioned by social context?  And if so, does this conditioning vary by 
age? 
 
Conceptualizing the Relationship between Social Environment 
and Heritability of Longevity 
Attempting to understand the genetic component of longevity without considering 
how it may be modified by specific environmental factors may not be a fruitful approach 
to gaining insights into the heritability of this complex trait (Petronis, 2010).  The 
heritability of certain phenotypes may vary throughout the life course (Turkheimer, 
Haley, Waldron, D'Onofrio, & Gottesman, 2003) and by gender (Visscher, Hill, & Wray, 
2008).  Given that humans are constantly interacting with the environment and the 




environmental influences might modify the heritability of longevity.  Accordingly, in this 
analysis, comparisons of heritability will be made between three subgroups of the 
population based on: 1) religious involvement; 2) early disease and nutritional 
environment; and 3) family environment during childhood.   
This study assumes that the same genes affect longevity across environments 
within a population, but certain attributes of the environment serve to moderate the effect 
of genes on phenotypic variation.  Shanahan and Hofer (2005)  have presented a 
framework for gene and social context interactions that has been used to explain the 
relationship between the social environment and health behaviors (Boardman, 2009; 
Boardman et al., 2012).  We present a slightly modified version that also utilizes concepts 
presented by Hoffmann and Merilä (1999) as well as new modifications to help formulate 
our hypotheses.   
Under Shanahan and Hofer’s framework for gene-environment (GxE) 
interactions, the environment is conceptualized as social context (Shanahan & Hofer, 
2005).  Four perspectives, described in detail below, can be used to depict how the social 
environment might affect heritable variation: triggering, compensation, social control, 
and enhancement.  Figures 4.1 – 4.4 show a modified version of a schema presented by 
Sebastiani et al. (2012) describing the genetic components of aging.  Sebastiani et al. 
have hypothesized that individuals living to exceptional ages have gerontogenes, but the 
longevity assurance genes counter the deleterious effects of genetic and environmental 
factors.  Figure 4.1 shows the proportion of total phenotypic variance (VT) that is 
attributable to additive genetic variance (VA) and environmental variance (VE), where the 
phenotype is longevity after age 30.  We show that in a normal environment where there 




heritability of gerontogenes and individuals with exceptional life-spans have higher 
heritability of longevity assurance genes.   
A triggering effect refers to an environment that interacts with personal 
predispositions to a diseased state and shortened life-span through, for example, 
environmental stressors or other factors that induce a biological change.  Figure 4.2 
shows the hypothesized triggering GxE interaction in which an adverse environment 
directly affects the phenotype.  When triggering mechanisms are responsible for 
environmental differences in heritability, we expect to see a decrease in average 
longevity in adverse environments and an increase in additive genetic variance.  This is 
because the environment leads to phenotypic expression that would otherwise be 
dormant.  This relationship may change with exceptional longevity because selection 
mechanisms may change the heritability of a trait over time. If the genetically frail 
individuals are selected out of this population at an earlier age, the surviving population 
may be comprised of more robust individuals with a genetic predisposition for 
exceptional longevity (i.e., longevity assurance genes; Hawkes, Smith, & Blevins, 2012), 
leading to higher levels of heritability of exceptional longevity in environments 
detrimental to health.  Therefore, under this formulation, we expect that individuals 
exposed to an unhealthy environment during childhood will have higher heritability of 
longevity, but a shorter life-span compared to those living in more advantageous 
circumstances.  This may also translate into higher heritability of exceptional longevity in 
unhealthy environments because only the robust in an unhealthy environment survive to 
exceptional ages.   
The second type of GxE interaction is compensation.  According to this 




and shortened life-span is realized but not in enriched settings.  The expected change in 
additive genetic variance in an enriched environment is presented in Figure 4.3.  The 
compensation GxE perspective assumes that the continuous exposure to a healthy 
environment prevents the expression of a genetic diathesis that predisposes an individual 
to premature death.  Unlike the triggering mechanism, the relationship between 
environment and phenotype is not causal, but due to environmental variation.  Therefore, 
we would expect to see an increase in average life expectancy in an enriched environment 
with lower additive genetic variance for the longevity phenotype.   
 Social control is the third GxE model.  This interaction is not presented in Figures 
4.1 – 4.4 because the expected outcomes are similar to those presented in Figure 4.3.  
Heritability of longevity may be attenuated in environments with high social control 
because social norms and structural constraints place limits on choices, and, therefore the 
environment suppresses phenotypic variance.  This is similar to the evolutionary 
argument of canalization, which argues that selection favors suppression of quantitative 
traits in constant and structured environments, but the genotype maintains a potential for 
expressing certain phenotypes under particular environmental conditions (Hoffmann & 
Merilä, 1999).  Thus, involvement with a religious institution that maintains strong social 
norms for health related behaviors such as alcohol consumption, smoking, social support, 
and dietary restrictions may lead to increased longevity and exceptional longevity for all 
members of the group and suppress genetic predispositions for disease.  In this situation, 
we expect to see increased longevity and exceptional longevity for active religious 
participants with lower levels of heritability compared to nonparticipants.     
 The enhancement model of GxE is presented Figure 4.4.  This is similar to the 




span, social context can serve to enhance genetic predispositions for longevity.  
Individuals in advantaged and organized social settings may be more apt to realize their 
genetic potential for longevity, while disadvantaged environments lead to unrealized 
potential.  For example, an environment of undernutrition or high levels of exposure to 
infectious agents may lead to physiological changes that alter an individual’s ability to 
reach their genetic potential (Barker, 1995; Barker et al., 1993; Crimmins & Finch, 
2006).  Here, we would expect to see mean differences in survival between environments 
and higher heritability of life-span and exceptional longevity in environments more 
advantageous for health and longevity.   
 In this paper, we build on a body of literature that examines the heritability of 
longevity by comparing heritability of longevity and exceptional longevity between sub-
populations exposed to different environments that are known to affect adult mortality 
risks.  Using the GxE perspectives discussed above, we compare the heterogeneity of 
genetic effects by environment.  We expect to see differences in the heritability of 
longevity between environments characterized as salubrious or unhealthy.  The GxE 
categories of triggering, compensation, and social control predict higher levels of 
heritability of longevity in environments less beneficial to health, while the enhancement 
typology predicts increased heritability of longevity in healthy environments.  We can 
make generalizations about what type of GxE interaction leads to the observed patterns, 
but the exact mechanism is not testable under this formulation.  Comparing the 
components of variance between environments will add to the understanding of the 










 The majority of life-span epidemiological studies examine health influences of 
early and adult life conditions with relatively modest sample sizes, particularly given the 
complexity of the phenomena and the manifold exposures and outcomes. This study 
utilizes data drawn from the Utah Population Database (UPDB). The UPDB is one of the 
world’s richest sources of linked population-based information for demographic, genetic, 
and epidemiological studies. UPDB has supported biodemographic studies as well 
numerous important epidemiological and genetic studies in large part because of its size, 
pedigree complexity, and linkages to numerous data sources. In the mid-1970s, over 
185,000 three-generation families were identified on Family Group Sheets from the 
archives at the Utah Family History Library.  These families have been linked into 
multigenerational families and the full UPDB now contains data on nearly 7 million 
individuals due to longstanding and on-going efforts to add new sources of data and 
update records as they become available.   
Mortality data are fundamental to the study of exceptional longevity.  Information 
on deaths prior to 1904 comes from genealogical records obtained from the Utah Family 
History Library and linked to other records within the UPDB.  All Utah death certificates 
are available from 1904 to the present.  The UPDB also links to the U.S. Social Security 
Death Index (SSDI) for the years 1936 – 2011.  The SSDI records provide information on 
deaths based on Social Security records regardless of place of death and are linked to the 
UPDB.  The unique combination of genealogy, death certificates, and SSDI data provide 




The sample used to construct measures of longevity comprises all individuals in 
the UPDB born between 1850 and 1927.  We selected 1927 as the maximum birth year to 
allow us to observe mortality to at least age 85 for the youngest members of the cohort.  
To minimize variability in survival unrelated to aging and based on other evidence of the 
fixed attributes related to life-span after age 30 (Yashin & Iachine, 1997), we will model 
mortality beginning at age 30 (Hawkes et al., 2012).  We identified 685,949 individuals 
who met the criteria listed above.  Of those, approximately 9% (n=64,258) were right 
censored and 91% (N=621,961) had vital status follow-up information from family 
history group sheets, Utah death certificates, or linked Social Security Death Index 
(SSDI) information.  The gender distribution of the sample was 52.5% male and 47.5% 
female.   
Using individuals from the baseline survival analysis, we selected 111,324 three-
generation families.  Table 4.1 shows the restrictions imposed at the family level.  We 
attempted to select families with the highest data quality and the most complete 
information. As a result, 31,322 families were excluded from the analysis because at least 
one grandparent had no information in the UPDB.  All founding pedigree members were 
required to have a birth year greater than 1850 (Utah was settled in 1847) and all 
members of the family were required to be born before 1928, which allowed us to 
observe the youngest members of the cohort to age 84.  On average, these families had 4 
individuals in the first generation (by definition), 13 individuals in the second generation, 
and 19 individuals in the third generation (range = 1 to 83).  Pedigree size ranged from 7 
to 109 members. The final sample consisted of 802 three-generation families with 20,120 
members with a calculated longevity measure and information on family of origin.  To 




born between 1914 and 1927 were excluded from the exceptional longevity sample, 
yielding a sample of 14,618 individuals for these analyses.   
 
Measuring Early and Midlife Environments 
 
Both early and midlife conditions will be considered as possible social context 
that may modify phenotypic expression.  To simplify both the measurement and 
conceptualization of the environment, each environment is treated as a simple dichotomy, 
comparing salubrious environments to those that are less advantageous to health.  We 
will compare the heritability of longevity by religious participation, infant mortality rate 
(IMR) in the family of origin, childhood mortality rate (CMR) of the family of origin, 
and number of siblings.   Justifications for each as the basis for deleterious and beneficial 
environments are described in turn below. 
Religious involvement in general is associated with increased life expectancy 
(Hummer, Rogers, Nam, & Ellison, 1999).  It is not surprising that active affiliation with 
the Church of Jesus Christ of Latter-day Saints (LDS or Mormon) church is also 
associated with increased life expectancy (Enstrom & Breslow, 2008).  Individuals 
actively affiliated with the LDS church are more likely to abstain from alcohol and 
tobacco use, fast once a month, and participate in church related social activities (Mineau, 
Smith, & Bean, 2002).  Therefore, affiliation with the LDS church  will be treated as a 
social environment with defined healthy lifestyle norms for men and women.  The UPDB 
contains information on baptism dates from family history records, which were used to 
classify individuals as followers of the LDS church.  Individuals baptized as members of 




Individuals will be parsed into two environments: 1) LDS church involvement; and 2) no 
LDS church involvement.     
 Early life health can have long-term consequences on later life health and 
mortality (Elo & Preston, 1992; Smith, Mineau, Garibotti, & Kerber, 2009).  While it is 
difficult to obtain a measure of early life exposure to disease and other adverse 
circumstances, we can use mortality outcomes of siblings as a sentinel for early life 
circumstances.  Postneonatal mortality (the first year of life excluding the first 28 days) 
for our cohorts of study (1850 – 1927) is closely related to viral and bacterial disease, 
malnutrition, and income (B. K. Finch, 2003; McKeown, 1976; Preston & Haines, 1991).  
A similar argument has been made for childhood mortality by Crimmins and Finch 
(2006), who argue that birth cohorts with lower childhood mortality have increased 
longevity.  As such, we use the death of a sibling during the first year of life (IMR in 
family of origin) or between ages 1 and 5 (CMR in family of origin) as indicators of an 
adverse childhood environment.  Neonatal deaths, deaths within the first 28 days, and 
stillbirths are not included in our final measure of IMR because these deaths are likely 
due to endogenous causes and may not represent a family environment marked by 
disease, an assumption most likely to be true for the years considered here.  We consider 
infant and childhood mortality as distinct environments because it has been suggested 
that the determinants of infant and childhood mortality decline over time differed during 
this period (Wolleswinkel-van den Bosch, van Poppel, Looman, & Mackenbach, 2000).  
Individuals with one or more infant or childhood death in their family of origin (i.e., 
death of a sibling) were considered to be in an environment of high infant or childhood 




 Sibship size (number of siblings) has been shown to be positively associated with 
lower educational achievement and unhealthy lifestyle choices (Downey, 1995; Hart & 
Davey Smith, 2003).  Sibship size may also be related to exposure to infectious diseases, 
with children from large sibships having a greater risk of contracting an infectious 
disease (Hart & Davey Smith, 2003).  However, a strong association between sibship size 
and adult mortality has not been demonstrated in all studies assessing this relationship 
(Smith et al., 2009).  The definition of large sibship was derived empirically as having 7 
or more siblings (75
th
 percentile for the sample).   
 While sex is inherently a biological trait, sex differences in life expectancy are 
determined by both social and biological factors (Crimmins & Saito, 2001; Lindahl-
Jacobsen et al., 2013; Rieker, Bird, & Lang, 2010).  The effects of early life conditions on 
later life health may differ by sex.  Male fetuses have higher mortality rates than female 
fetuses, a disadvantage that continues throughout the life course (Kraemer, 2000).  Earlier 
studies have found slight differences in the heritability of longevity between males and 
females, with males having higher heritability than females (Herskind et al., 1996).  
Accordingly, we test for environmental differences in the heritability of longevity by sex.   
 
Definition of Longevity 
 
The mortality schedule for individuals born between 1850 and 1927 has changed 
considerably. Longevity, therefore, defined simply as years lived after age 30, is not 
appropriate because it is not directly comparable across birth cohorts.  While much of the 
improvement in life expectancy seen during this period was due to improvements in 
infant and child mortality, there were also gains in adult mortality.  Cohort life tables for 




additional 40.5 and 39.5 years for females and males, respectively, compared to 53.1 and 
48.5 years of additional life after 30 for individuals born in 1920 (Lindahl-Jacobsen et al., 
2013).  Therefore, to de-trend the data, we define longevity as the difference between an 
individual’s attained age (y) and the age to which that individual was expected to live 
(median predicted age of death conditioned on surviving to 30,   ̂) according to a model 
that incorporates two basic determinants of life-span: gender and birth year.  Therefore, a 
longevity score (LS) is simply the difference between these two values, y -  ̂.  The 
baseline survival models used to determine  ̂ are described below. This approach is 
similar to one taken by Kerber et al. (2001) in calculating a measure of familial excess 
longevity using Utah genealogies.   
Previous studies have suggested that the heritability of longevity increases with 
age (Hjelmborg et al., 2006; Yashin & Iachine, 1997), and may perhaps be the strongest 
for those surviving to the latest ages (Atzmon et al., 2004; Gudmundsson, Gudbjartsson, 
Frigge, Gulcher, & Stefánsson, 2000; T. T. Perls, Bubrick, Wager, Vijg, & Kruglyak, 
1998).  Exceptional longevity can be defined as an exceptionally long life-span compared 
to other individuals experiencing the same historical influences (birth cohort; Michael 
Anson et al., 2012).  As done in previous studies, we will define the exceptional 
longevity (EL) phenotype as living to exceptional age, and explore differences in 




 percentile based on the baseline hazard models 
(Kerber, O'Brien, Boucher, Smith, & Cawthon, 2012).   
 
Constructing Baseline Survival Models 
We assume a parametric form for the survival distribution and a generalized class 




models.  Unlike proportional hazard models, AFT models assume that the effect of 
covariates is multiplicative with respect to survival time.  We test the fit of the 
exponential, Weibull , log-normal, log-logistic, and gamma  models.  These models were 
selected because they provide a simple point estimate for duration that generally fits the 
observed data for adult mortality.  While the gompertz model is appropriate for modeling 
human mortality between 30 and 85 (Olshansky & Carnes, 1997), this study is concerned 
with exceptional longevity (past the age of 85) and therefore this model was not 
considered.  The nested structure of the family of generalized gamma models 
(exponential, Weibull, log-logistic, and gamma) allows for use of the likelihood ratio test 
to assess model fit.  The Akaike information criterion, or AIC, can be used to test the fit 
of nonnested models.  Final models were selected for the construction of the longevity 
measures based on model fit. 
The full sample of 685,949 individuals born between 1850 and 1927 meeting the 
sample criteria described in the data section above were used to estimate survival time for 
individuals surviving to age 30.  Models were stratified by gender and included two 
covariates, birth year, and birth year squared.  All models showed a significant positive 
relationship between birth year and survival.  The generalized gamma model proved to be 
the best fit based on likelihood ratio test (p<0.001) and AIC.  The shape and scale 
parameters in the generalized gamma model are also significantly different than “0” and 
“1,” implying that the fitted distribution is different from the Weibull, log-normal, and 




 percentile by model and 
year is displayed in Figure 4.5.  Panels A and B show the trend in predicted median and 
90
th
 percentile longevity respectively for men and panels C and D display the estimates 




not shown.  These figures show that the log-normal and log-logistic models, which 
provided the worst fit based on the AIC statistic, also predict out of range values for the 
90
th
 percentile.  Both the Weibull and generalized gamma model provide sensible 
estimates.  Therefore, the generalized gamma model was used to estimate  ̂ and 
consequently LS.  
 LS was defined as the observed, minus the expected, life-span for all deceased 
individuals.  The UPDB contains multiple sources of linked records that can be used to 
create a last observed date.  Therefore, we know that individuals without a death record 
were alive until their last observed date in UPDB.  The observed life-span for individuals 
born after 1905, not deceased, and with a known follow-up date that exceeded the median 
predicted survival time for their gender and birth cohort is calculated by subtracting the 
birth year from the last observed date in UPBD.  Therefore, censored individuals that are 
likely still living were used in the LS analyses and have a positive LS score by definition.  
To test for biased results created by this specification, we ran sensitivity analysis using 
the nearly deceased cohort (N=14,618).  
 
Heritability Estimates 
Several forms of analysis of variance (ANOVA) are available to measure 
heritability of a phenotypic trait, such as parent-offspring regressions and sibling 
analyses.  While these models have useful features, they are limited because they do not 
use information from multigenerational relationships and they require that sample sizes 
be well-balanced.  Unlike other forms of analysis of variance (ANOVA), maximum 
likelihood (ML) estimators do not place special demands on the design or balance of the 




pedigrees (Lynch & Walsh, 1998) and minimizing the inflation of estimates of additive 
genetic variance due to shared environments between relatives.  To allow for use of 
information on multigenerational relationships, heritability is estimated with a polygenic 
model using PAP v. 7.1 (Hasstedt, 2005).   
Genotypic variance can be decomposed into additive     , dominance     , and 
epistatic     .     and    are, however, extremely difficult to estimate in non-
experimental settings (Kruuk, 2004).  The polygenic model specifies the expected genetic 
relationship between relatives as a function of the coefficient of relationship, allowing for 
the estimation of variation due to genetic and residual environmental effects.  The 
coefficient of relationship is (1/2)
p
, where p is the degree of relationships (it is also 
commonly described as two times the probability that two individuals will share a 
common gene by descent (IBD)).  For example, for a parent-child relationship the 
coefficient of relationship is 0.5, which equals 2 x 0.25, where 0.25 is the probability that 
parent and child share a common allele.  The polygenic model allows us to partition the 
total phenotypic variance (  
 ) into the following components: 
  
    
     
  (eq. 4.1) 
where   
  is the additive genetic variance and   
  is the residual variance, which includes 
environmental, dominance, and epistatic effects.    These components are used to 
calculate heritability, with narrow sense heritability (h
2
) being defined as the proportion 
of phenotypic variance,   
 
, that can be attributed to the additive genetic effects,   
 : 
        h
2
=  
 /  
   (eq. 4.2) 
   The polygenic model is similar to a mixed model with fixed and random effects. The 
general model in matrix form is: 




where y is a column vector containing the phenotypic values for a trait measured in n 
individuals; β is a vector of fixed effects; u is a vector of random effects; X and Z are 
known incidence matrices; and e is a column vector of random residual effects.  We 
assume that u follows a multivariate normal (MVN) distribution with mean zero and 
variance G, and that e also follows a MVN distribution with mean zero and variance R.  
Note that G =   
 A, where A is an n x n matrix of kinship coefficients describing the 
genetic correlation between all individuals in the sample, and R=  
 I, where I is the 
identity matrix.  This general model can be used to estimate the variance components for 
a single trait (univariate model) and has been extended to allow for joint modeling of 
multiple traits (bivariate for two traits and multivariate for multiple traits).  The univariate 
model was used to estimate the heritability of LS and exceptional longevity in the 
population.  We then use the multivariate model to estimate h
2
 by environment. 
The multivariate model provides a means for estimating covariance and, 
therefore, correlation between traits.  Falconer (1952) suggested that traits measured in 
two environments can be treated as two different traits.  This allows comparisons 
between discrete environments of different types, where the bivariate model defines a 
trait as being expressed in environment one or two.  For example, if individual i is in 
environment one, they have a value for trait one and are missing trait two.  Conversely, if 
individual j is in environment two, they are missing trait one and have a value for trait 
two.  This approach is more appropriate than stratification, because it allows for the joint 
estimation of heritability in two subpopulations.  It is also slightly different than a normal 
bivariate trait model, which jointly models two phenotypes measured on the same 




k traits (in our case k=2) are combined to form a vector   [
  
  
]= (y11, … , y1n, …, y2n) 
with mean µz and variance G.   The model in matrix notation is,  
    [
   




]   [
   







] (eq. 4.4) 
where y1 and y2 are vectors of phenotypic values in environment one and two, 
respectively; β1 and β2 are the vectors of the fixed effects in environment one and two, 
respectively; a1 and a2 are the vectors of the random additive genetic effects in 
environment one and two, respectively; e1 and e2 are the vectors of random residual 
effects for environment one and two, respectively; X1 and X2 are the known incidence 
matrices relating the observations to the respective fixed effects in environments one and 
two; and W1 and W2 relate the observations to the random effects in environments one 
and two.   
The variance-covariance matrix for Z can be expressed as V = G + R     
     , where G is the Kronecker product of C and A      .  C is the k x k matrix of 
additive genetic covariances, and E is the k x k residual covariance matrix.  A and I are 
respectively the n x n kinship coefficient and identity matrices, with cij=σA(i,j) being the 
additive genetic covariance between characters i and j within an individual and cross-
covariance cijAlm being the additive genetic value of character i in individual l and the 
additive genetic value of character j in individual m (Lynch & Walsh, 1998, p. 777).  In a 
bivariate analysis, C is a 2 x 2 matrix of the form:   
  [
  
           
         
    
] (eq. 4.5) 
where   
     and   
     are the additive genetic variances for traits 1 and 2, respectively, 




Defining the environment at the individual level and estimating heritability using 
the multivariate model without defining the genetic correlation between traits leads to 
biased estimates of heritability because heritability estimates from an environment only 
include information about family members in the same environment.  To correct for this 
problem, we assume perfect genetic correlation between the trait values.  A bivariate 
analysis that explicitly models genetic correlations exploits more information content of 
the data (Amos, de Andrade, & Zhu, 2001).  The genetic correlation between traits can be 
defined as: 
     
       
√   
    
 
 (eq. 4.6) 
where            
   and    
  are all components of variance mentioned above and 
                   .  By constraining      to 1, we are requiring the covariance 
between traits to equal the square-root of the product of the variances and forcing the 
model to include information from both environments.  Constraining the genetic 
correlation to unity allows for heritability and additive genetic variance to vary in both 
environments, but requires them to be dependent.  In a bivariate trait analysis, where both 
phenotypes are measured for an individual, the genetic correlation is often estimated and 
used to describe the pleiotropic nature of the traits.  However, estimating the genetic 
correlation across environments would be erroneous in our situation because when 
    , we are only using partial information from the pedigree because the covariance is 
weighted by the correlation coefficient (          ).  Algebraically, this solves the bias 
problem because it forces the measure of additive genetic variance for each environment 




conceptually plausible because a genetic correlation of 1 indicates the effect of the same 
polygenes on the trait in both environments.    
LS was Box-Cox transformed and standardized (µ=0, σ=1) to improve 
computational performance and abide by distributional assumptions of the variance 
components models. The transformation was performed using Proc transreg in SAS, 
which uses a maximum likelihood approach to find the optimal transformation, which in 
this cases was λ=1.75.  This transformation reduced the skewness coefficient from -0.85 
to -0.26.  The simple correlation between the transformed variable and the original 
measure of LS was 0.98.   
 To test the hypothesis of heterogeneity in heritability, the likelihood ratio statistic 
was used.  Models were estimated, allowing heterogeneity in heritability estimates 
between environments, and compared to models where the heritability estimates were 
constrained to be equal across environments.  Sex and birth year were not considered as 
covariates in the model because they were controlled for when creating the measures of 





 Figure 4.6 shows the distribution of LS for the baseline survival cohort and the 
sample selected for the heritability estimates.  Both distributions are slightly skewed with 
means of -1.2 and -1.7 for the full cohort and the heritability cohort, respectively.   The 
skewed distribution reflects the change in the rate of mortality between ages 30 and the 
median predicted survival time for an individual’s sex and cohort.  Cohort life tables for 




0.05 at age 60 and 0.29 at age 80 (Lindahl-Jacobsen et al., 2013).  Therefore, it is not 
unexpected to see the long left tail in the LS distribution.  The distributional skew is due 
to a combination of factors including model fit (the fit provides a good approximation of 
the survival curve, but does not fit the data exactly) and censoring of the youngest cohort.   
Table 4.2 shows the descriptive statistics for individuals in the heritability 
samples.  The longevity sample includes all 20,120 individuals with calculated longevity, 
LS, from the 802 selected pedigrees.  Individuals in the exceptional longevity sample 
were required to be born before 1914 so that we could observe survival in the UPDB to 
age 99.  Approximately 8% of males and females in this sample survive to the 90
th
 
percentile for their cohort and sex.  This number is slightly smaller than 10% because the 
cut point for the 90
th
 percentile is derived from the baseline survival models.   Forty-eight 
percent of the sample is female and approximately three-fourths of the sample was 
affiliated with the LDS church.  All members of a family with a sibling that died during 
infancy or childhood are counted as having an infant death in their family of origin and in 
historical cohorts.  Children from large families experience excess infant and childhood 
mortality rates (Bean, Mineau, & Anderton, 1990; Knodel & Hermalin, 1984), so this 
percentage is slightly higher than the 17.4% and 18.5% percent of nuclear families with 
an infant or childhood death, respectively.  There is not a substantial amount of overlap in 
these measures, with 6.4% of nuclear families having both an infant and childhood death.   
Figure 4.7 shows the effect of environment on LS without considering family 
structure.  Significant differences in LS exist in all environments.   Panel A shows the 
distribution of LS by religious status, with individuals not affiliated with the LDS church 
on average having a 2 point reduction in longevity score (p<0.001).  The distribution of  




respectively, with individuals having one or more sibling die during the postneonatal 
period having a 2 point reduction in LS (p<0.001), and individuals with one or more 
sibling deaths during childhood having a 1.5 reduction in LS (p<0.001).  Panel D shows 
the distribution of LS by sibship size and illustrates the nearly 2-point reduction of LS for 




 The overall heritability of LS in the sample is 0.18, which is within the range of 
previously reported estimates.  We find that in the four environments considered when 
not conditioned on sex, the mean LS is lower in unhealthy environments but there are no 
significant differences in h
2
.   The pattern of heritability of LS by environment is 
somewhat mixed, with higher heritability of LS in environments with low IMR and 
CMR, but lower heritability of LS in the other two healthy environments.   It is important 
to note that heritability is a population statistic, thus we are comparing subpopulations 
defined by an environment and not average individual differences in phenotype.  The 
addition of environment-specific means and variances significantly improve model fit for 
all environments, with lower means and environmental variances in environments that are 
considered beneficial to longevity.   
To further investigate sex differences in heritability and GxE interactions, we 
considered models separately by sex.  In a bivariate model, considering only sex 
differences, we find that heritability of LS is significantly lower for females compared to 
males, h
2




= 9.03, p=0.003), and there is little difference 
between the mean and environmental variances by gender.  The lack of difference in the 




survival models were stratified by sex), and therefore one would not expect to see gender 
differences in the average LS. 
Multivariate models were used to calculate the heritability estimates for LS by 
environment and sex (results in Table 4.3).  When considering the differences in 
heritability of LS by sex and environment, the mean differences in LS by environment 
are similar, with lower mean LS in environments considered unhealthy.  We find no 
significant differences in the heritability of LS by environment with the exception of 
female environments classified by CMR, which show a 9 point difference in h
2
LS between 
the healthful and unhealthful environments.  The heritability of LS is lower in female 
environments with high CMR when compared to female environments with low sibling 
CMR (LR χ2=5.88, p=0.015).  This is in contrast to the higher heritability of LS clustered 
about a lower mean LS in the male environment with high CMR compared to an 
environment with low CMR, although these differences are not significant.  For females, 
there is little difference in total phenotypic variance between the two CMR 
subpopulations (  
  is approximately 1.30 and 1.29 in high CMR and low CMR 
subpopulations, respectively). This is supportive of the enhancement hypothesis, which 
suggests that individuals are unable to realize there genetic potential in adverse 
environments. 
Sensitivity analyses using the nearly deceased cohort (n=14,618) were run for the 
LS models.  We found that heritability estimates were slightly smaller (0.17 vs. 0.18 in 
the larger sample), but the observed differences by gender and environment were all in 









 percentile conditioned 
on birth year and sex.  The sample for these analyses is smaller than the sample used to 
obtain estimates of heritability of LS because observing EL requires a nearly extinct 
cohort (NLS=20,120, NEL= 14,618).   Heritability estimates for the two phenotypes were 
very similar, with h
2
EL=0.352 when EL is defined as survival to the 90
th
 percentile 
(shown in Table 3.4), and h
2
EL=0.345 (95% CI= 0.244, 0.447) when EL is defined as 
survival to the 95
th





 percentiles suggests that heritability does not increase linearly 
with age, and that perhaps there is an upper limit to increases in heritability of longevity.  
However, the differences are negligible and not relevant to the main hypotheses of this 
paper.  Therefore, we show results for survival to the 90
th
 percentile conditioned on age 
and sex.   
Table 4.4 shows the heritability estimates for EL by environment and gender.  We 
find that heritability for EL is nearly twice the heritability of LS (0.18 vs. 0.35).  
Bivariate models were used to test for environmental differences in the heritability of EL. 
We find that allowing the prevalence to vary by environment significantly improves 
model fit, with higher prevalence of EL in healthful environments.  We find no difference 
in heritability of EL by environment when not conditioned on gender.  There are also no 
gender differences in the heritability of EL (LR χ2= 0.552, p=0.46), which differs from 
the LS findings.  
 When using the multivariate model to test for environmental differences in 
heritability of EL by gender and environment, we do not find evidence of significant 
differences with the exception of the male CMR environment.  The heritability of EL is 




with low CMR (LR χ2=4.25, p=0.04), and there is no difference in the prevalence of 
exceptional longevity between environments.  This suggests that a triggering GxE 
interaction may be operating through selection mechanisms, where the frail are selected 
out of the adverse populations at faster rates and only the genetically robust individuals 
with longevity assurance genes that are able to thwart the effects of gerontogenes survive 
to exceptional ages.   
 
Discussion 
Our analysis of longevity is based on information from 20,120 individuals from 
802 three-generation families used to examine the heritability of longevity, defined as 
survival after age 30.  We also estimated the heritability of exceptional longevity using 
information from a subset of that sample (n=14,618 ) that is nearly extinct.  Our findings 
support previous studies suggesting a moderate heritable component to longevity that 
increases with age (Herskind et al., 1996; Hjelmborg et al., 2006; Kerber et al., 2001), 
although the adult ages at which this assessment is made varies across analyses.  We find 





suggesting that the increase in proportion of variance due to genetic factors may not be a 
constant linear increase as suggested by other studies (Hjelmborg et al., 2006).  We find 
that sex differences in the heritability of longevity after age 30 support other studies 
showing higher heritability of longevity for males (Herskind et al., 1996), but no sex 
differences in the heritability of exceptional longevity.  We investigated the heterogeneity 
of longevity and exceptional longevity by early and midlife social environments.  We 




overall there is not strong support of a gene-environment interaction for the selected 
environments.   
We find evidence that childhood environments marked by high child mortality, 
indicative of exposure to infectious disease and undernutrition for the surviving members, 
may affect the proportion of phenotypic variation attributable to genetic factors.  The sex 
and age differences of the effects suggest an enhancement GxE interaction because 
adverse childhood circumstances limit the genetic potential of individuals to survive to 
older ages.  Conceptually, CMR is used to identify environments with excess exposure to 
infectious disease and undernutrition.  For females, genetic factors contribute little to the 
total variance in longevity in such environments, which suggests that genetic potential is 
not reached in such environments.  While a similar pattern exists for EL, the difference in 
heritability between environments is not significant.   
We see the opposite effect for male environments, although the observed patterns 
do not necessarily conflict with the female results.  Males have a mortality disadvantage 
relative to females throughout the life course that is partially due to biological factors 
(Kraemer, 2000).  Therefore, they may be more susceptible to environmental conditions 
that trigger genetic predispositions for disease and lead to higher mortality selection 
compared to females reared in the same environment.  The difference in the direction of 
the effect for males suggests that the adverse environment may actually trigger genetic 
diatheses, with higher heritability clustered about a lower mean longevity in deleterious 
environments, but these differences are not significant.  This results in higher heritability 
of exceptional longevity because individuals surviving to this age have some 
predisposition or genetic robustness that prevented them from being selected out of the 




 It is interesting that we find heterogeneity in CMR environments, but not in 
environments characterized by IMR.  This may be partially due to differences in specific 
causes of death for the two groups, as suggested by Wolleswinkel-van den Bosch et al. 
(2000).  We did consider variations of our definition of IMR, which included neonatal 
deaths, although this did not change the substantive conclusion that heritability of 
longevity does not vary between subpopulations with different rates of infant mortality.   
While we find some evidence of heterogeneity in the heritability of longevity 
between environments, heritability estimates seem to be fairly impervious to early and 
midlife circumstances.   Herskind et al. (1996) reported stability of heritability estimates 
over sex and cohort during periods of rapid change in living conditions.  However, the 
birth cohorts selected for that study would still be children during periods with higher 
childhood mortality (1870 – 1900) than experienced during modern times.  Our results 
suggest that improvements in social and health conditions that have caused declines in 
childhood mortality may lead to a higher proportion of variability in longevity 
attributable to genetic factors.  More research needs to be done to test for other 
environmental differences in the heritability of longevity, including socioeconomic status 
and fertility history.   
The nearly twofold increase in heritability of exceptional longevity compared to 
the heritability of longevity after age 30 suggests that selection mechanisms may affect 
the heritability of longevity throughout the life course.  Individuals without longevity 
assurance genes may be selected out of the population at early ages, leaving a subset of 
the population that is made up of a higher proportion of robust individuals.  While the 
heritability of longevity increases with age, exceptional longevity is still only moderately 




also remarkable that there are gender differences in heritability of longevity after age 30, 
but not with respect to exceptional survival.  This suggests that individuals surviving to 
exceptional ages have survived mortality selection because they have a genetic variant 
that increases the ability to handle stress and/or counteract deleterious effects of the 
environment or generontogenes.  This is further supported by other research suggesting 
the buffering role of longevity genes (Bergman, Atzmon, Ye, MacCarthy, & Barzilai, 
2007; Sebastiani et al., 2012).  
Epigenetics is one of several possible biological mechanisms that allow social 
circumstances to get “under the skin,” and it recently has been suggested that epigenetic 
changes have the propensity to persist across subsequent generations (Feinberg, 2007).  
This is a provocative idea that lends support to mutligenerational transmission of social 
disparities.  More research needs to be done to uncover the possible mechanisms leading 
to phenotypic variation across social environments and the possibility of transmitting the 
adverse effects to subsequent generations.  We suggest further study into the possibility 
of GxE interactions and health and longevity outcomes.  While we did not find an 
association between all environments, there is a suggestion that the social environment 
may play an important role in modifying the heritability of longevity.   
In this paper, we assessed variation in heritability estimates of longevity after age 
30.  However, other cutoffs, such as postreproductive aging, should also be considered.  
Further modeling of heterogeneity of variance and the variance of longevity across other 
environments could be valuable in understanding how the social environment moderates 
the genetic component to aging.  Care should be taken when interpreting polygenic 
heritability when the genetic correlation has been fixed to unity, because it is assumed 




assumption for subgroups of a single population, the reader should be aware of this 
constraint. 
To our knowledge, this is the first study using multigenerational pedigree 
information to investigate heterogeneity in heritability of longevity across multiple early 
and midlife environments.  Studies in other fields have examined heterogeneity in 
variance components by gender and age using a similar method (Giolo, Pereira, de 
Andrade, Krieger, & Soler, 2010; Pilia et al., 2006), lending validity to this approach. 
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Table 4.1.  Pedigree Selection 
 
    3 Generation Families from 
1850 - 1927 Cohort* 
111,324 
    
Exclusions 
     Families missing information 
on at least one grandparent 




    At least one of the 




A member of G3 born after 
1927 
26,420 
    Total Number of 3-
Generation Families for 
Analysis 
802 
    *This is calculated by taking any member of the BC and ascending 3 
generations.  The result is 111,324 distinct treetops (defined by the unique 
combination of maternal and paternal grandparents).  Families that did not 
meet our selection criteria were then excluded. 
 
































Longevity Score (LS) -1.7 (15.2) -1.9 (15.5) 
 
-2.3 (15.4) -2.7 (16.5) 
Survived to the 90th Percentile (EL) 
   
8.4% 8.0% 
Survived to the 95th Percentile 
   
4.2% 3.9% 
Baptized Latter-Day Saint 72.5% 74.4% 
 
75.6% 77.7% 
One or more Postneonatal Infant 
Deaths in Family of Origin 19.5% 19.7% 
 
23.9% 23.1% 
One or more Childhood Deaths in 
Family of Origin 19.5% 19.9% 
 
23.1% 24.2% 
Large number of Siblings 29.6% 29.2%   35.6% 35.6% 
 








































Figure 4.1. Hypotheses for GxE interactions: Expected.  The expected phenotypic 






Figure 4.2. Hypotheses for GxE interactions: Triggering.  A triggering GxE interaction in 






Figure 4.3. Hypotheses for GxE interactions: Compensation.  A compensation GxE 





Figure 4.4. Hypotheses for GxE interactions: Enhancement.  An enhancement interaction 







Figure 4.5.  Predicted values of survival to the 50th and 90th percentiles by gender and 




 percentile estimates,  
respectively.  Panels C and D show estimates for female 50
th
 and  
90
th








Figure 4.6. Distribution of calculated longevity for individuals born between 1850 and 
1927 and surviving to age 30.  Panel A shows the distribution for the cohort used in the  
baseline survival analysis (N=685,949).  Panel B shows the distribution for the  








Figure 4.7.  Distribution of longevity by environment.  Empirical densities of longevity 
are plotted by environment.  Panel A shows the distribution of longevity by LDS status.  
Panel B shows the distribution of longevity by infant mortality in family of origin.  Panel 
C shows the distribution of longevity by childhood mortality in family of origin.  Panel D 























This dissertation investigated heterogeneity in patterns of aging and the factors 
throughout the life course that shape them.  By focusing on variability within the 
population we are able to provide a clearer picture of how circumstances throughout the 
life course affect the way individuals age.  We found that the paths to disease and 
longevity are diverse and that early and midlife factors play an important role in 
determining later life health and longevity.  Our results support a wide body of literature 
showing that morbidity is not an inevitable consequence of aging, even in the oldest old 
population, but is shaped by the historical circumstances and social environments that we 
live in.   This study offered innovative and significant contributions to the understanding 
of biological and socioenvironmental determinants of aging.  Our research sought to 
disentangle the biological and temporal sources of trends in cancer incidence, 
investigating the possible social and physiological effects of fertility history on 
comorbidity trajectories after age 65, and studying the heterogeneity in the heritable 
components of the total phenotypic variation in longevity across early life family and 




Fully understanding the sources of heterogeneity in the patterns of aging and 
longevity using only measures of the early life or proximate environment is an impossible 
endeavor because the biological functioning of an individual is dependent upon a vast 
array of circumstances from birth to death.  Healthy aging and longevity phenotypes 
should be characterized as plastic and not one fixed at or near the time of birth.  Trends in 
cancer incidence in the oldest old are sensitive to period and cohort influences.  Fertility 
history affects disease progression later in life and these effects are independent of early 
life circumstances, including a family history of longevity.  These findings suggest that 
childhood is not the only malleable period in the life course; midlife circumstances may 
also alter the trajectories of age related degeneration.  The moderate heritability of 
exceptional longevity is evidence that genes are not the only factor contributing to this 
phenotype.  There is also some evidence that heritability of longevity is sensitive to 
childhood environments.   Therefore, it is essential to consider how events throughout the 
life course and their interrelationships influence aging and longevity.   
Little is known about age-specific disease incidence and prevalence among the 
oldest old (Boscoe, 2008; Christensen, Johnson, & Vaupel, 2006).  This study highlighted 
the heterogeneity of disease patterns in this population by analyzing age, period, and 
cohort (APC) effects on cancer incidence in the oldest old and individual trajectories of 
disease for two cohorts over an 18 year period.  We found significant evidence of 
variance in disease patterns for this population and evidence that social context and 
events throughout the life course influence patterns of disease even for the exceptionally 
long lived.  The APC analyses provided evidence that the decline in cancer incidence for 
this age group is not strictly related to biological phenomenon.  Characterizing 




provides evidence that even into these advance ages the patterns of disease are diverse.  
We found that there are distinct heterogeneous patterns of comorbidity that range from a 
robust group, escaping major morbid conditions for the majority of the observation 
period, to a frail group characterized by high comorbidity throughout the entire period of 
observation.  These findings underscore the importance of more rigorous and 
interdisciplinary research into the biological and social underpinnings of disease for this 
rapidly increasing segment of the population.   
It is important to consider how mortality selection shapes age-related patterns of 
disease.  While it is clear that longevity is only moderately heritable at extreme ages, 
heritability also increases with age.  This suggests that there may be genetic variants that 
are protective against deleterious genetic and environmental effects.  The buffering 
mechanisms in aging hypothesis suggests that longevity genes buffer against the harmful 
effects of deleterious genotypes (Huffman et al., 2012).  The decline in cancer incidence 
above age 90 also suggests that individuals reaching the extreme ends of longevity may 
be less susceptible to disease.  However, the diverse patterns of comorbidity experience 
provide evidence that longevity is not synonymous with disease free living.  
 
Future Research 
Sociological and demographic studies of aging and longevity should inform and 
be informed by the fields of genetics, epidemiology, and biology.  More attention should 
be given to uncovering genetic and biological pathways to health and their interaction 
with the social environment.  The integration of theories of aging from multiple 
disciplines is essential to unraveling the secrets of this multifactorial process.  It is 




individuals from those with multiple morbidities and a shortened life-span; however, it is 
clear that these differences cannot be wholly explained by biological or social 
mechanisms.  Therefore, future demographic work should continue to improve upon the 
specification of biological and social paths to health outcomes.  
 The studies presented in this dissertation utilized a range of tools to describe 
aging and longevity trends in the populations.  Each of these tools has unique aspects that 
can be leveraged to further advance the field of aging and longevity.  Age, period, and 
cohort (APC) analyses can be considered descriptive.  It is not possible to make causal 
statement as to what factors led to the observed trends.  However, this is not sufficient 
reason for demographers to abandon APC analyses.  It is the ability to describe the 
multidimensionality of morbidity and mortality trends that give these analyses so much 
power and point to domains that may hold some of the answers to fundamental questions 
about the origins of longevity.   
Making definitive statements about age-related trends using cross-sectional data 
or longitudinal data from a single cohort is a dangerous practice.  The observed trends in 
cross-sectional data may be confounded by cohort differences in exposure, while 
longitudinal data from a small number of cohorts are not generalizable because the 
observed patterns may be specific to these cohorts.  Therefore, we advocate a 
decomposition approach to understanding the underlying factors of disease by first 
defining age, period, and cohort effects of morbidity and cause-specific mortality.  This 
first step does not provide a complete explanation for the trends, but it helps to elucidate 
what needs to be explained.   The second step then involves further investigating the 
components and interrelationships in order to make more definitive causal statements 




considerable light on the ways that social environments intersect with biological factors 
determining disease.   
 The use of group-based trajectory modeling to construct heterogeneous patterns of 
aging is extremely informative to the studies of aging and longevity.  It has become clear 
that there is not a linear pattern of decline in physiological function determined by 
chronological age at the population or individual level.  Assessing unique patterns of 
disease and disability experience give us a more realistic picture of how people age.  We 
also have much to learn about which experiences throughout the life course contribute to 
specific patterns of aging.  Other sources of early life information, such as linked 
Decennial Censuses and military service records, will be available as part of the UPDB 
infrastructure in the near future.  This will allow for further investigation into the 
association between early and midlife events and later life morbidity.  We also suggest 
that study is warranted for investigating specific diseases or groups of disease (rather than 
composite measures only) with similar biological underpinnings to further understand the 
association between fertility and later life health.  
 Exploring gene-environment (GxE) interactions using a multigenerational 
database with information on early and midlife conditions is a fruitful approach to 
understanding how the social environment affects later life health.  Not only can the 
study presented here be expanded to include other environments, but it can also be 
expanded to examine variation in heritability of other aging phenotypes.  For example, 
we identified a group of robust individuals that experienced low levels of disease over an 
18 year period in the trajectory analysis.  It would be interesting to see if there is evidence 
of heritability of a “robust” phenotype.  Other ways of investigating GxE interactions 




and telomere length, to investigate the possibility of environmentally altered phenotypic 
expression.     
 Population projections that assume future gains in healthy life expectancy and life 
expectancy in general will remain on a fixed path should be viewed with caution because 
life expectancy is sensitive to both historical and current sociological context.  This is not 
to say that future improvements in healthy life expectancy and life expectancy in general 
are impossible, but they are dependent upon factors that are still not well understood.  
Also, much more research needs to be conducted in order to understand disease 
trajectories specific to the oldest old population.  We cannot plan for proper care of this 
rapidly increasing population when we know so little about their healthcare needs.   
 
Conclusions 
This research contributes to a growing body of literature that draws attention to 
effects of early life circumstances on later life health.  Health policies should be aimed at 
promoting the well-being of individuals throughout the life course.  This research 
specifically highlights the importance of maternal well-being during childbearing years.  
The future health of women is not only affected while they are in their reproductive 
years, but it has been shown to affect the health of her offspring (Gluckman & Hanson, 
2005).  Therefore special attention should be given to this sensitive period that may alter 
the health of multiple generations.  This research also highlights the importance of social 
context throughout the life course in determining later life health.  Health risks are 
created and maintained by social structures and more work must be done to understand 
the social disparities that lead to disparities in health later in life and possibly across 




review health and cancer screening recommendations of the past.  The view that this age 
group is too frail or has too many comorbid conditions should be reconsidered (Østbye, 
Greenberg, Taylor, & Lee, 2003) based on trends in cancer incidence for this population.    
   Understanding the sources of variation in patterns of aging is important for 
creating accurate population predictions, identifying at risk populations that may benefit 
from public health interventions, and characterizing the process of aging in a diverse 
population.  Rather than focusing on the average life expectancy or healthy life 
expectancy of the population and their trends over time, we should be focusing on the 
variability of these measures within a population and changes in the sources of variation 
over time.  This is a subtle but important difference.  By elucidating mechanisms that 
lead to heterogeneous patterns of aging, we can not only gain more insight into the 
determinants of aging, but focus on the factors that have the largest impact.  Health 
policy should be focused on not only curing ailments once they present themselves, but 
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